RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
NOVELLO S
Collezione AOU San Luigi di Orbassano
Items : 270
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial. in Lancet (London, England) / Lancet. 2024 Sep 28;404(10459):1240-1252. doi: 10.1016/S0140-6736(24)01756-2. Epub 2024 Sep 14.
2024
AOU San Luigi di Orbassano
Spicer JD; Garassino MC; Wakelee H; Liberman M; Kato T; Tsuboi M; Lee SH; Chen KN; Dooms C; Majem M; Eigendorff E; Martinengo GL; Bylicki O; Rodríguez-Abreu D; Chaft JE; Novello S; Yang J; Arunachalam A; Keller SM; Samkari A; Gao S;
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database. in ESMO open / ESMO Open. 2024 Sep;9(9):103680. doi: 10.1016/j.esmoop.2024.103680. Epub 2024 Aug 29.
2024
ASL Asti
AOU San Luigi di Orbassano
Baldini E; Di Micco C; Banini M; Calvetti L; Leone F; Carta A; Pignataro D; Pozzessere D; Muscolino P; Bria E; Citarella F; Pilotto S; Cortinovis D; Gariazzo E; Pelizzari G; Roca E; Galetta D; Sini C; Delmonte A; Bulotta A; Occhipinti M; Minuti G; Cappuzzo F; Reale ML; Passiglia F; Favaretto A; Malapelle U; Novello S; Pasello G; et alii...
Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated Non-Small-Cell Lung Cancer with brain metastases: a meta-analysis and systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 Oct 30:104540. doi: 10.1016/j.critrevonc.2024.104540.
2024
AOU San Luigi di Orbassano
Nepote A; Poletto S; Bertaglia V; Carnio S; Piumatti C; Lanzetta C; Cantale O; Saba G; Bironzo P; Novello S; Tralongo AC;
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Oct;196:107921. doi: 10.1016/j.lungcan.2024.107921. Epub 2024 Aug 6.
2024
AOU San Luigi di Orbassano
Waterhouse DM; Rothschild S; Dooms C; Mennecier B; Bozorgmehr F; Majem M; van den Heuvel MH; Linardou H; Chul Cho B; Roberts-Thomson R; Tanaka K; Blais N; Schvartsman G; Holmskov Hansen K; Chmielewska I; Forster MD; Giannopoulou C; Stollenwerk B; Obiozor CC; Wang Y; Novello S;
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Nov;197:107990. doi: 10.1016/j.lungcan.2024.107990. Epub 2024 Oct 21.
2024
AOU San Luigi di Orbassano
Bertolaccini L; Tralongo AC; Del Re M; Facchinetti F; Ferrara R; Franchina T; Graziano P; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Cinquini M; Passiglia F; Novello S;
HER2-Altered Non-Small Cell Lung Cancer: A Journey from Current Approaches to Emerging Strategies. in Cancers / Cancers (Basel). 2024 May 26;16(11):2018. doi: 10.3390/cancers16112018.
2024
AOU San Luigi di Orbassano
Ferrari G; Del Rio B; Novello S; Passiglia F;
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 May;191:107787. doi: 10.1016/j.lungcan.2024.107787. Epub 2024 Apr 5.
2024
AOU Alessandria
AOU San Luigi di Orbassano
Troncone G; Righi L; Genova C; Tiseo M; Pilotto S; Pasello G; Piovano P; Pagni F; Graziano P; Garbo E; Cortinovis D; Fraggetta F; Galetta D; Lucia Reale M; Pisapia P; Novello S; Pepe F; Passiglia F; Malapelle U;
Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 May;197:104328. doi: 10.1016/j.critrevonc.2024.104328. Epub 2024 Mar 13
2024
AOU Città della Salute di Torino
ASL Torino 4
AOU San Luigi di Orbassano
Di Maio M; Novello S; Sperone P; Vellani G; Vignani F; Dionisio R; Paratore C; Valsecchi AA; Ferrari G;
HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI. in Future oncology (London, England) / Future Oncol. 2024 May;20(15):969-980. doi: 10.2217/fon-2023-0602. Epub 2023 Dec 14.
2024
AOU San Luigi di Orbassano
Meng J; Sternberg DW; Fougeray R; Fan PD; Wu YL; Steuer C; Reck M; Novello S; Nishio M; Jänne PA; Mok T; Esker S; Yu HA;
Novel RAF-directed approaches to overcome current clinical limits and block the RAS/RAF node. in Molecular oncology / Mol Oncol. 2024 Jun;18(6):1355-1377. doi: 10.1002/1878-0261.13605. Epub 2024 Feb 16.
2024
AOU San Luigi di Orbassano
Scardaci R; Berlinska E; Scaparone P; Vietti Michelina S; Garbo E; Novello S; Santamaria D; Ambrogio C;
CT-Guided Core Needle Biopsy of Pulmonary Lesions Associated With Cystic Airspaces: A Case-Control Study. in AJR. American journal of roentgenology / AJR Am J Roentgenol. 2024 Jul;223(1):e2431042. doi: 10.2214/AJR.24.31042. Epub 2024 May 8.
2024
ASL Cuneo 2
AOU San Luigi di Orbassano
Veltri A; Righi L; Sverzellati N; Novello S; Bironzo P; Levra S; Napoli F; Senkeev R; Filipello F; Barba M; Culasso NC; Caroli A; Balbi M; Capelli S;
A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study. in ESMO open / ESMO Open. 2024 Jul;9(7):103624. doi: 10.1016/j.esmoop.2024.103624. Epub 2024 Jun 28.
2024
AOU San Luigi di Orbassano
Avancini A; Giannarelli D; Borsati A; Carnio S; Cantale O; Nepote A; Mangiapane F; Bafunno D; Galetta D; Longo V; Tregnago D; Trestini I; Belluomini L; Sposito M; Insolda J; Schena F; Milella M; Novello S; Pilotto S;
SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Jan 20;42(3):324-335. doi: 10.1200/JCO.23.01363. Epub 2023 Nov 17.
2024
AOU San Luigi di Orbassano
Tam SH; Ozawa Y; Novello S; Navarro A; Johnson M; Ozyilkan O; Chiu CH; Rittmeyer A; Dumoulin DW; Bryl M; Lee JS; Hong MH; Lu S; Soo RA; Liu SV; Rudin CM; Patil NS; Wen X; Huang M; Hoang T; Meng R; Reck M;
Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Jan;19(1):166-172. doi: 10.1016/j.jtho.2023.08.004. Epub 2023 Aug 9.
2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; Remon J; Bironzo P; Genova C; Facchinetti F; Aldea M; Le Péchoux C; Novello S; Barlesi F; Besse B; Planchard D; Tagliamento M;
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report. in Journal of personalized medicine / J Pers Med. 2024 Apr 8;14(4):394. doi: 10.3390/jpm14040394.
2024
AOU Alessandria
AOU San Luigi di Orbassano
Bironzo P; Galetta D; Pasello G; Novello S; Ceresoli GL; Davolio MC; Abate-Daga L; Dianzani I; Pisapia P; Malapelle U; Sculco M; Grosso F; Tiseo M; Barbisan F; Rossi G; Righi L; Spagnolo P;
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study. in Frontiers in oncology / Front Oncol. 2024 Jul 9;14:1436588. doi: 10.3389/fonc.2024.1436588. eCollection 2024.
2024
AOU San Luigi di Orbassano
Sposito M; Belluomini L; Nocini R; Insolda J; Scaglione IM; Menis J; Simbolo M; Lugini A; Buzzacchino F; Verderame F; Spinnato F; Aprile G; Calvetti L; Occhipinti M; Marinelli D; Veccia A; Lombardo F; Soto Parra HJ; Ferraù F; Savastano C; Porta C; Pradelli L; Sicari E; Castellani S; Malapelle U; Novello S; Bria E; Pilotto S; Milella M; et alii...
Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review. in Cancers / Cancers (Basel). 2023 Sep 28;15(19):4774. doi: 10.3390/cancers15194774.
2023
AOU San Luigi di Orbassano
Garbo E; Del Rio B; Ferrari G; Cani M; Napoli VM; Bertaglia V; Capelletto E; Rolfo C; Novello S; Passiglia F;
The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2023 Sep;18(9):1146-1164. doi: 10.1016/j.jtho.2023.05.028. Epub 2023 Jun 16.
2023
AOU San Luigi di Orbassano
Farinea G; Crespi V; Listì A; Righi L; Bironzo P; Merlini A; Malapelle U; Novello S; Scagliotti GV; Passiglia F;
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial. in Journal for immunotherapy of cancer / J Immunother Cancer. 2023 Oct;11(10):e007047. doi: 10.1136/jitc-2023-007047.
2023
AOU San Luigi di Orbassano
Zhou C; Srivastava MK; Xu H; Felip E; Wakelee H; Altorki N; Reck M; Liersch R; Kryzhanivska A; Oizumi S; Tanaka H; Hamm J; McCune SL; Bennett E; Gitlitz B; McNally V; Ballinger M; McCleland M; Zou W; Das Thakur M; Novello S;
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC. in The New England journal of medicine / N Engl J Med. 2023 Nov 16;389(20):1839-1850. doi: 10.1056/NEJMoa2309457. Epub 2023 Oct 21.
2023
AOU San Luigi di Orbassano
Zhou C; Solomon B; Loong HH; Park K; Pérol M; Arriola E; Novello S; Han B; Zhou J; Ardizzoni A; Mak MP; Santini FC; Elamin YY; Drilon A; Wolf J; Payakachat N; Uh MK; Rajakumar D; Han H; Puri T; Soldatenkova V; Lin AB; Lin BK; Goto K;
Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Nov 1;41(31):4852-4863. doi: 10.1200/JCO.23.01361. Epub 2023 Sep 11.
2023
AOU San Luigi di Orbassano
Goto K; Goto Y; Kubo T; Ninomiya K; Kim SW; Planchard D; Ahn MJ; Smit EF; de Langen AJ; Pérol M; Pons-Tostivint E; Novello S; Hayashi H; Shimizu J; Kim DW; Kuo CH; Yang JC; Pereira K; Cheng FC; Taguchi A; Cheng Y; Feng W; Tsuchihashi Z; Jänne PA;
RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape. in The oncologist / Oncologist. 2023 May 8;28(5):402-413. doi: 10.1093/oncolo/oyac264.
2023
AOU San Luigi di Orbassano
Novello S; Califano R; Reinmuth N; Tamma A; Puri T;
Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes. in Life (Basel, Switzerland) / Life (Basel). 2023 May 31;13(6):1291. doi: 10.3390/life13061291.
2023
AOU San Luigi di Orbassano
Mogavero A; Bironzo P; Righi L; Merlini A; Benso F; Novello S; Passiglia F;
Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies. in International journal of molecular sciences / Int J Mol Sci. 2023 May 17;24(10):8883. doi: 10.3390/ijms24108883.
2023
AOU San Luigi di Orbassano
Cani M; Napoli VM; Garbo E; Ferrari G; Del Rio B; Novello S; Passiglia F;
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2023 May 12;42(1):120. doi: 10.1186/s13046-023-02690-5.
2023
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Novello S; Ponzetto C; Bardelli A; Di Nicolantonio F; Pietrantonio F; Poli V; Monteleone E; Bironzo P; Benso F; Tabbò F; Zambelli V; Listì A; Castella B; Volante M; Negrino C; Rospo G; Oddo D; Napoli F; Russo M; Scagliotti GV; Righi L; Morena D; Picca F; Bersani F; Taulli R;
Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer. in Scientific reports / Sci Rep. 2023 May 12;13(1):7759. doi: 10.1038/s41598-023-33954-x.
2023
AOU Novara
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Vattakunnel S; Bussolino F; Sandri A; Sabbatini G; Primo L; Righi L; Pittaro A; Papotti M; Parab S; Novello S; Monica V; Guerrera F; Gandolfi L; Errico L; Falco P; Doronzo G; Colombi D; Corà D; Corti G; Cipollini F; Bianco S; Bironzo P; Manganaro L; Scagliotti GV;
Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2023 May;179:107173. doi: 10.1016/j.lungcan.2023.03.009. Epub 2023 Mar 15.
2023
AOU San Luigi di Orbassano
Reck M; Popat S; Grohé C; Corral J; Novello S; Gottfried M; Brueckl W; Radonjic D; Kaiser R; Heymach J;
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial. in Lancet (London, England) / Lancet. 2023 Mar 4;401(10378):733-746. doi: 10.1016/S0140-6736(23)00221-0. Epub 2023 Feb 7.
2023
AOU San Luigi di Orbassano
de Langen AJ; Johnson ML; Mazieres J; Dingemans AC; Mountzios G; Pless M; Wolf J; Schuler M; Lena H; Skoulidis F; Yoneshima Y; Kim SW; Linardou H; Novello S; van der Wekken AJ; Chen Y; Peters S; Felip E; Solomon BJ; Ramalingam SS; Dooms C; Lindsay CR; Ferreira CG; Blais N; Obiozor CC; Wang Y; Mehta B; Varrieur T; Ngarmchamnanrith G; et alii...
Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer? in EClinicalMedicine / EClinicalMedicine. 2023 Feb 6;57:101845. doi: 10.1016/j.eclinm.2023.101845. eCollection 2023 Mar.
2023
AOU San Luigi di Orbassano
Passiglia F; Novello S;
Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapy. in Cancer / Cancer. 2023 Jun 1;129(11):1662-1671. doi: 10.1002/cncr.34731. Epub 2023 Mar 11.
2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Bironzo P; Scagliotti GV; Righi L; Novello S; Di Maio M; Passiglia F; Listì A; Napoli VM; Jacobs F; Cani M;
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®). in Tumori / Tumori. 2023 Jun;109(3):324-334. doi: 10.1177/03008916221099558. Epub 2022 Jun 8.
2023
ASL Torino 4
AOU San Luigi di Orbassano
Iannelli Patient E; D'Acunti A; Nicelli A; De Persis D; Bassi M; Ferrari A; Bagnalasta M; Capelletto E; Adamo V; Cognetti F; Passalacqua R; Tortora G; Maruzzo M; Cogoni AA; Lorusso V; Calabrò F; Falzetta A; Cinieri S; Del Mastro L; Procopio G; Porta C; Novello S; Sparavigna L; Iezzi E; Diodati F; Ng D; Mitchell SA; Perrone F; Riva S; et alii...
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience. in Biomedicines / Biomedicines. 2023 Jan 9;11(1):165. doi: 10.3390/biomedicines11010165.
2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Novello S; Passiglia F; Scagliotti GV; D'Amiano C; Gianetta M; Di Maio M; Capelletto E; Bianco V; Napoli VM; Leone G; Turco F; Audisio A; Cecchi C; Delcuratolo MD; Cetoretta V; Parlagreco E; Pisano C; Garbo E; Ferrari G; Bironzo P; Persano I; Del Rio B; Cani M; Bertaglia V;
Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey. in JTO clinical and research reports / JTO Clin Res Rep. 2022 Dec 15;4(1):100446. doi: 10.1016/j.jtocrr.2022.100446. eCollection 2023 Jan.
2023
AOU San Luigi di Orbassano
Mezquita L; Novello S; Besse B; Bironzo P; De Maria A; Giaj Levra M; Remon J; Tagliamento M;
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2023 Feb 1;29(3):621-634. doi: 10.1158/1078-0432.CCR-22-0761.
2023
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Hirsch E; Taulli R; Grignani G; D'Ambrosio L; Modica C; Vigna E; Mariniello A; Tabbò F; Napoli F; Salaroglio IC; Riganti C; Righi L; Basiricò M; Gammaitoni L; Vujic I; Sanlorenzo M; Peirone S; Medico G; De Santis MC; Massa A; Galvagno F; Donini C; Leuci V; Rotolo R; Cereda M; Aglietta M; Scagliotti GV; Novello S; Bironzo P; et alii...
Drive the oncologists into exercise promotion in lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2023 Feb;176:1-3. doi: 10.1016/j.lungcan.2022.12.009. Epub 2022 Dec 22.
2023
AOU San Luigi di Orbassano
Novello S; Pilotto S; Schena F; Milella M; Belluomini L; Avancini A;
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer. in The New England journal of medicine / N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3.
2023
AOU San Luigi di Orbassano
Wakelee H; Liberman M; Kato T; Tsuboi M; Lee SH; Gao S; Chen KN; Dooms C; Majem M; Eigendorff E; Martinengo GL; Bylicki O; Rodríguez-Abreu D; Chaft JE; Novello S; Yang J; Keller SM; Samkari A; Spicer JD;
Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Apr;184:103954. doi: 10.1016/j.critrevonc.2023.103954. Epub 2023 Mar 5.
2023
ASL Torino 3
AOU San Luigi di Orbassano
Scartozzi M; Tampellini M; Denaro N; Manunta S; Aiello MM; Solinas C; Morelli AM; Bertaglia V; Novello S;
RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center. in Personalized medicine / Per Med. 2022 Sep;19(5):395-401. doi: 10.2217/pme-2022-0020. Epub 2022 Jul 8.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Rosell R; Molina-Vila MA; Novello S; Cortinovis DL; Gridelli C; Daniele B; Iannaci G; Laudati S; Rocco D; Bellevicine C; Vigliar E; Fabozzi T; Russo M; Conticelli F; Nacchio M; Pagni F; Campione S; Russo G; Listì A; Righi L; Iaccarino A; Pisapia P; Pepe F; Luca C; Troncone G; Malapelle U;
Clinical-Molecular Prospective Cohort Study in Non-Small Cell Lung Cancer (PROMOLE study): A Comprehensive Approach to Identify New Predictive Markers of Pharmacological Response. in Clinical lung cancer / Clin Lung Cancer. 2022 Sep;23(6):e347-e352. doi: 10.1016/j.cllc.2022.05.007. Epub 2022 May 11.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Pirri F; Bussolino F; Manganaro L; Candeloro S; Righi L; Novello S; Primo L; Bironzo P; Scagliotti GV;
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer. in Cells / Cells. 2022 Oct 14;11(20):3226. doi: 10.3390/cells11203226.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Geuna M; Bironzo P; Passiglia F; Righi L; Sangiolo D; Novello S; Paratore C; Di Maio M; De Filippis M; Bungaro M; Bertaglia V; Mecca C; Consito L; Carnio S; Capelletto E; Listì A; Reale ML; Rezmives NA; Tesauro M; Indellicati D; Tabbò F; Mariniello A;
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Oct;174:200-211. doi: 10.1016/j.ejca.2022.07.026. Epub 2022 Aug 28.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Righi L; Novello S; Graziano P; Scagliotti GV; Bria E; Volante M; Rossi A; Rossi G; Osman G; Di Maio M; Bareggi C; Del Conte A; Cappuzzo F; Cortinovis D; Pilotto S; Gregorc V; Sergi C; Ghilardi L; Scotti V; Martelli O; Tiseo M; Galetta D; Maiello E; Rigutto A; Castellana S; Trombetta D; Gobbini E; Tabbò F; Muscarella LA; et alii...
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling. in BMC cancer / BMC Cancer. 2022 Nov 24;22(1):1212. doi: 10.1186/s12885-022-10296-x.
2022
AOU San Luigi di Orbassano
Pilotto S; Trestini I; Buffoni L; Ferrari A; Pedrazzoli P; Caccialanza R; Cereda E; Agustoni F; Klersy C; Casirati A; Montagna E; Carnio S; Novello S; Milella M;
Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform. in Scientific reports / Sci Rep. 2022 May 18;12(1):8342. doi: 10.1038/s41598-022-12056-0.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Vansteenkiste J; Bironzo P; O'Brien M; Mazieres J; Paz-Ares L; Felip E; Gorlia T; Dziadziuszko R; Berghmans T; Janži? U; Dooms C; Stevovic A; Novello S; Morfouace M; Lacroix L; Dingemans AC; Golfinopoulos V; Besse B;
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients. in Clinical lung cancer / Clin Lung Cancer. 2022 May;23(3):e243-e246. doi: 10.1016/j.cllc.2021.07.008. Epub 2021 Jul 20.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Besse B; Juan O; Mosquera J; Cousin S; Sampayo M; Greillier L; Bernabé R; de Castro J; Bigay-Game L; Novello S; Girard N; Remon J;
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 May;167:98-106. doi: 10.1016/j.lungcan.2022.01.008. Epub 2022 Jan 22.
2022
AOU San Luigi di Orbassano
Lantuéjoul S; Fernandez-Cuesta L; Letouzé E; Demontrond P; Audigier-Valette C; Girard N; Giaj Levra M; Cadranel J; Mondet J; Novello S; Antoine M; Brevet M; Foll M; Mc Leer A; Moro-Sibilot D;
Nutritional support in lung cancer: Time to combine immunonutrition with immunotherapy? in Nutrition (Burbank, Los Angeles County, Calif.) / Nutrition. 2022 Jun;98:111637. doi: 10.1016/j.nut.2022.111637. Epub 2022 Mar 3.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Pedrazzoli P; Novello S; Milella M; Trestini I; Bironzo P; Cereda E; Lobascio F; Morelli AM; Agustoni F; Pilotto S; Caccialanza R;
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Jul;169:94-101. doi: 10.1016/j.lungcan.2022.05.009. Epub 2022 May 19.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Dingemans AC; von der Thüsen J; Remon J; Reguart N; O'Brien M; Reck M; Novello S; Mauer M; Lantuejoul S; Hendriks L; Greillier L; Girard N; Faivre-Finn C; Edwards J; De Ruysscher D; Brandão M; Bironzo P; Berghmans T; Giaj Levra M; Sperduti I; Menis J; Pilotto S; Avancini A; Milella M; Besse B;
Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements. in Cancers / Cancers (Basel). 2022 Jan 30;14(3):718. doi: 10.3390/cancers14030718.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Reale ML; Novello S; Jacobs F; De Filippis M; Pisano C;
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jan;169:103536. doi: 10.1016/j.critrevonc.2021.103536. Epub 2021 Nov 18
2022
AOU Città della Salute di Torino
ASL Torino 4
AOU San Luigi di Orbassano
Rocco D; Migliorino MR; Parra HS; Pagni F; Seminati D; Passaro A; Tiseo M; Cortinovis D; Galetta D; Belluomini L; Pepe F; Pisapia P; Passiglia F; Reale ML; Malapelle U; Pilotto S; Troncone G; Novello S;
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Jan;33(1):57-66. doi: 10.1016/j.annonc.2021.09.017. Epub 2021 Oct 5.
2022
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU San Luigi di Orbassano
Scagliotti GV; Caffo O; Irtelli L; Wiest G; Monica V; Porcu L; Manegold C; Dickgreber NJ; Bearz A; Pedrazzoli P; Follador A; Folprecht G; Griesinger F; Schmid-Bindert G; Reck M; Morabito A; Santo A; Gregorc V; Chiari R; Schena M; Borra G; Valmadre G; Ceribelli A; Kropf-Sanchen C; Stoelben E; Geissler M; Colantonio I; Cauchi C; Ladage D; et alii...
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jan;169:103525. doi: 10.1016/j.critrevonc.2021.103525. Epub 2021 Nov 20
2022
ASL Torino 4
AOU San Luigi di Orbassano
Russo A; Righi D; Pasini S; Perrone G; Pagni F; Novello S; Mastrilli F; Gristina V; Galvano A; Barberis M; Baggi A; Troncone G; Pisapia P; Pepe F; Malapelle U;
Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Jan;11(1):117-121. doi: 10.21037/tlcr-22-27.
2022
AOU San Luigi di Orbassano
Zhang J; Roviello G; Novello S; Mariniello A; Pérez-Ríos M; Zhang K; Tartarone A;
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2022 Feb 23;41(1):75. doi: 10.1186/s13046-022-02284-7.
2022
AOU Città della Salute di Torino
ASL Torino 4
AOU San Luigi di Orbassano
Riganti C; Scagliotti GV; Papotti MG; Novello S; Bussolino F; Righi L; Taulli R; Leo F; Grosso F; Gazzano E; Comunanza V; Libener R; Sandri A; Facolmatà C; Fontana S; Napoli F; Ricci L; Digiovanni S; Ananthanarayanan P; Bironzo P; Belisario DC; Salaroglio IC; Kopecka J;
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC). in Cancer treatment reviews / Cancer Treat Rev. 2022 Feb;103:102335. doi: 10.1016/j.ctrv.2021.102335. Epub 2021 Dec 31.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Novello S; Ambrogio C; Swalduz A; Santamaria D; Pradines A; Planchard D; Nadal E; Mazieres J; Mezquita L; Pisano C; Tabbò F; Ortiz-Cuaran S;
Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2). in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2022 Dec;17(12):1404-1414. doi: 10.1016/j.jtho.2022.08.018. Epub 2022 Sep 10.
2022
AOU San Luigi di Orbassano
Ou SI; Nishio M; Ahn MJ; Mok T; Barlesi F; Zhou C; Felip E; de Marinis F; Kim SW; Pérol M; Liu G; Migliorino MR; Kim DW; Novello S; Bearz A; Garrido P; Mazieres J; Morabito A; Lin HM; Yang H; Niu H; Zhang P; Kim ES;
Immunohistochemistry with 3 different clones in anaplastic lymphoma kinase fluorescence in situ hybridization positive non-small-cell lung cancer with thymidylate synthase expression analysis: a multicentre, retrospective, Italian study. in Pathologica / Pathologica. 2022 Aug;114(4):278-287. doi: 10.32074/1591-951X-756. Epub 2022 Sep 8.
2022
AOU San Luigi di Orbassano
Bironzo P; Barbieri F; Maiello E; Migliorino MR; Lombardi A; Tiseo M; Righi L; Graziano P; Rossi G; Novello S; Melocchi L; Monica V; Trebeschi D;
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19
2022
ASL Asti
AOU Città della Salute di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Novello S; Scagliotti GV; Carnio S; Buffoni L; Passiglia F; Zichi C; Capelletto E; Reale ML; Artusio E; Olmetto E; Bertaglia V; Paratore C; Bungaro M; Curcio H; De Luca E; Tagliamento M; Audisio M; Rapetti SG; Bironzo P; Pignataro D; Di Maio M;
Strengths and pitfalls of brigatinib in non-small cell lung cancer patients' management. in Minerva medica / Minerva Med. 2022 Apr;113(2):315-332. doi: 10.23736/S0026-4806.21.07693-X.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Novello S; Jacobs F; DE Filippis M; Tabbò F;
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103602. doi: 10.1016/j.critrevonc.2022.103602. Epub 2022 Jan 19
2022
AOU San Luigi di Orbassano
Schmidinger M; Gori V; Novello S; Scavone C; Cucchiara F; Passiglia F; Del Re M; Tabbò F; Capuano A; Fogli S; Danesi R;
Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Apr;33(4):454. doi: 10.1016/j.annonc.2022.01.005. Epub 2022 Jan 25.
2022
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU San Luigi di Orbassano
Manegold C; Scagliotti GV; Torri V; Grohe C; Porcu L; Follador A; Monica V; Wiest G; Irtelli L; Dickgreber NJ; Bearz A; Caffo O; Pedrazzoli P; Chiari R; Reck M; Schmid-Bindert G; Folprecht G; Griesinger F; Gregorc V; Santo A; Stoelben E; Ceribelli A; Serke M; Morabito A; Schena M; Valmadre G; Borra G; Kropf-Sanchen C; Colantonio I; et alii...
NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images. in Cancers / Cancers (Basel). 2021 Sep 10;13(18):4543. doi: 10.3390/cancers13184543.
2021
AO Cuneo
AOU San Luigi di Orbassano
Novello S; Volante M; Farsad M; Terreno E; Delcuratolo MD; Capozza M; Righi L; Mariniello A; Liberini V; Deandreis D;
Winds From the ORIENT: New Data to Inform RATIONAL Choice? in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 Sep;16(9):1434-1436. doi: 10.1016/j.jtho.2021.07.003.
2021
AOU San Luigi di Orbassano
Bironzo P; Passiglia F; Novello S;
Repositioning PARP inhibitors in the treatment of thoracic malignancies. in Cancer treatment reviews / Cancer Treat Rev. 2021 Sep;99:102256. doi: 10.1016/j.ctrv.2021.102256. Epub 2021 Jul 7.
2021
AOU San Luigi di Orbassano
Passiglia F; Reale ML; Cetoretta V; Parlagreco E; Jacobs F; Listì A; Righi L; Bironzo P; Novello S; Scagliotti GV;
Effectiveness of a Psychosocial Care Quality Improvement Strategy to Address Quality of Life in Patients With Cancer: The HuCare2 Stepped-Wedge Cluster Randomized Trial. in JAMA network open / JAMA Netw Open. 2021 Oct 1;4(10):e2128667. doi: 10.1001/jamanetworkopen.2021.28667.
2021
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Passalacqua R; Maglietta G; Iezzi E; Diodati F; Zerilli F; Sarobba G; Russo A; Procopio G; Pazzola A; Novello S; Mattioli R; Gori S; Giordani P; Cinieri S; Caputo F; Aragona M; Airoldi M; Pinto C; Verusio C; Annunziata MA; Caminiti C;
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Nov 10;39(32):3633-3644. doi: 10.1200/JCO.20.03318. Epub 2021 Aug 26.
2021
AOU San Luigi di Orbassano
Ramalingam SS; Novello S; Guclu SZ; Bentsion D; Zvirbule Z; Szilasi M; Bernabe R; Syrigos K; Byers LA; Clingan P; Bar J; Vokes EE; Govindan R; Dunbar M; Ansell P; He L; Huang X; Sehgal V; Glasgow J; Bach BA; Mazieres J;
5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death Ligand 1-Positive Advanced Non-Small-Cell Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 May 25:S1556-0864(21)02172-9. doi: 10.1016/j.jtho.2021.05.001.
2021
AOU San Luigi di Orbassano
Herbst RS; Garon EB; Kim DW; Cho BC; Gervais R; Perez-Gracia JL; Han JY; Majem M; Forster MD; Monnet I; Novello S; Gubens MA; Boyer M; Su WC; Samkari A; Jensen EH; Kobie J; Piperdi B; Baas P;
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. in Cancers / Cancers (Basel). 2021 May 17;13(10):2425. doi: 10.3390/cancers13102425.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Scagliotti GV; Bussolino F; Righi L; Di Maio M; Passiglia F; Caglio A; Listì A; Sperone T; Tabbò F; Reale ML; Bironzo P; Novello S;
Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2021 May 12;13(10):2332. doi: 10.3390/cancers13102332.
2021
AOU Alessandria
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Taulli R; Novello S; Aviles P; Libener R; Sandri A; Leo F; Guerrera F; Comunanza V; Bussolino F; Gigliotti C; Pittaro A; Di Nicolantonio F; Papotti MG; Righi L; Napoli F; Morena D; Lingua MF; Picca F; Bironzo P; Anobile DP; Scagliotti GV; Riganti C;
Pericarditis during chemoimmunotherapy for non-small cell lung cancer: an adverse event to prevent and recognise. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:114-116. doi: 10.1016/j.ejca.2021.03.004. Epub 2021 Apr 12.
2021
AOU San Luigi di Orbassano
Novello S; Luciano A; De Stefanis P; Carnio S; Jacobs F;
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:74-83. doi: 10.1016/j.ejca.2021.01.015. Epub 2021 Feb 12.
2021
AOU San Luigi di Orbassano
Parra HS; Bianchi AS; Righi L; Pilotto S; Pietrantonio F; Pagni F; Loupakis F; Listì A; Lauricella C; Galetta D; Fontanini G; Fassan M; Cortinovis D; De Stefano A; Avallone A; Pepe F; Pisapia P; Reale ML; Cremolini C; Passiglia F; Malapelle U; Tiseo M; Verzè M; Troncone G; Novello S;
Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancer. in Future oncology (London, England) / Future Oncol. 2021 Mar;17(7):763-773. doi: 10.2217/fon-2020-0935. Epub 2020 Nov 5.
2021
AOU San Luigi di Orbassano
Novello S; F Loong HH; Lin BK; Lin AB; Sashegyi A; Soldatenkova V; Davis HM; Elamin Y; Wolf J; Park K; Drilon A; Zhou CC; Solomon BJ; Arriola E; Pérol M; Goto K; Santini FC;
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features. in Cancers / Cancers (Basel). 2021 Jun 11;13(12):2935. doi: 10.3390/cancers13122935.
2021
AOU San Luigi di Orbassano
Passaro A; Novello S; Giannarelli D; Bria E; Galetta D; Gelibter A; Reale ML; Carnio S; Vita E; Stefani A; Pizzutilo P; Stati V; Attili I; de Marinis F;
Exploring the immune-checkpoint inhibitors' efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2876-2889. doi: 10.21037/tlcr-20-635.
2021
AOU San Luigi di Orbassano
Passiglia F; Cetoretta V; De Filippis M; Napoli V; Novello S;
[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.]. in Recenti progressi in medicina / Recenti Prog Med. 2021 Jun;112(6):419-437. doi: 10.1701/3620.36025.
2021
AOU San Luigi di Orbassano
Esposito I; Calabria S; Piccinni C; Addesi A; Dondi L; Ronconi G; Pedrini A; Maggioni AP; Curigliano G; Listi A; Righi L; Novello S; Buglioni S; Ciliberto G; Pruneri G; Martini N;
Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Jul;157:9-16. doi: 10.1016/j.lungcan.2021.05.017. Epub 2021 May 24.
2021
AOU San Luigi di Orbassano
Kruhl C; Bent-Ennakhil N; Pérol M; Hochmair M; Helland Å; Griesinger F; Garassino MC; Felip E; Cadranel J; Brustugun OT; Popat S; Novello S;
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jul;151:211-220. doi: 10.1016/j.ejca.2021.03.011. Epub 2021 May 19.
2021
AOU San Luigi di Orbassano
Paz-Ares L; Dingemans AM; Planchard D; Mariniello A; Rossoni C; Charrier M; Naigeon M; Majem M; Zalcman G; Plodkowski AJ; Girshman J; Sawan P; Hellmann MD; Novello S; Reale ML; Tabbò F; Bironzo P; Blanc-Durand F; Carnio S; Audigier-Valette C; Ponce S; Ruffinelli JC; Martin-Romano P; Nadal E; Park W; Rizvi H; Hendriks L; Saravia D; Auclin E; et alii...
Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Jul;157:85-91. doi: 10.1016/j.lungcan.2021.05.009. Epub 2021 May 11.
2021
AOU San Luigi di Orbassano
Capelletto E; Bironzo P; Consito L; Bertaglia V; Reale ML; Tabbò F; Delcuratolo MD; Olmetto E; Leone G; Passiglia F; Novello S;
The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer. in JTO clinical and research reports / JTO Clin Res Rep. 2021 May 24;2(7):100194. doi: 10.1016/j.jtocrr.2021.100194. eCollection 2021 Jul.
2021
AOU San Luigi di Orbassano
Gitlitz BJ; Novello S; Vavalà T; Bittoni M; Sable-Hunt A; Pavlick D; Hsu R; Park SL; Chen R; Cooke M; Moore A; Schrock AB; Schiller JH; Addario BJ; Oxnard GR;
Local for advanced, is this a paradox? in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3324-3328. doi: 10.21037/tlcr-20-771.
2021
AOU San Luigi di Orbassano
Bungaro M; Paratore C; Bironzo P; Novello S;
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer. in Cancers / Cancers (Basel). 2021 Jan 4;13(1):139. doi: 10.3390/cancers13010139.
2021
AOU San Luigi di Orbassano
Rosell R; Molina-Vila MA; Novello S; Cortinovis DL; Bellevicine C; Vigliar E; Conticelli F; Tufano R; Nacchio M; Sgariglia R; Pagni F; De Dominicis G; Campione S; Gragnano G; Greco L; Listì A; Righi L; Iaccarino A; Pisapia P; Pepe F; De Luca C; Troncone G; Malapelle U;
Upfront Management of ALK-Rearranged Metastatic Non-small Cell Lung Cancer: One Inhibitor Fits All? in Current oncology reports / Curr Oncol Rep. 2021 Jan 2;23(1):10. doi: 10.1007/s11912-020-00989-6.
2021
AOU San Luigi di Orbassano
Novello S; Passiglia F; Tabbò F;
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103189. doi: 10.1016/j.critrevonc.2020.103189. Epub 2020 Nov 27
2021
AOU San Luigi di Orbassano
Passiglia F; Sperone P; Capelletto E; Artusio E; Carnio S; Di Stefano RF; Rapetti S; Audisio M; Bungaro M; Tabbò F; Leone G; Mariniello A; Palesandro E; Bironzo P; Reale ML; Bertaglia V; Novello S;
A Prospective Phase II Single-arm Study of Niraparib Plus Dostarlimab in Patients With Advanced Non-small-cell Lung Cancer and/or Malignant Pleural Mesothelioma, Positive for PD-L1 Expression and Germline or Somatic Mutations in the DNA Repair Genes: Rationale and Study Design. in Clinical lung cancer / Clin Lung Cancer. 2021 Jan;22(1):e63-e66. doi: 10.1016/j.cllc.2020.07.014. Epub 2020 Aug 5.
2021
AOU San Luigi di Orbassano
Scagliotti GV; Volante M; Novello S; Arizio F; Listì A; Righi L; Passiglia F; Bironzo P;
Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Feb;152:127-134. doi: 10.1016/j.lungcan.2020.12.011. Epub 2020 Dec 17.
2021
AOU San Luigi di Orbassano
Novello S; Mukhametshina GZ; Schumacher M; Rizzato S; Ostoros G; Tsoi D; Gottfried M; Metro G; Migliorino MR; Passaro A; Hochmair M; Egorova I; Poltoratskiy A; Laktionov KK; de Marinis F; Dziadziuszko R; Tang W; Clementi L; Cseh A; Kowalski D;
Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study. in JTO clinical and research reports / JTO Clin Res Rep. 2020 Oct 26;2(2):100114. doi: 10.1016/j.jtocrr.2020.100114. eCollection 2021 Feb.
2021
AOU San Luigi di Orbassano
Yang JC; Reckamp KL; Kim YC; Novello S; Smit EF; Lee JS; Su WC; Akerley WL; Blakely CM; Groen HJM; Bazhenova L; Carcereny Costa E; Chiari R; Hsia TC; Golsorkhi T; Despain D; Shih D; Popat S; Wakelee H;
Humoral immune response to SARS-CoV-2 in five different groups of individuals at different environmental and professional risk of infection. in Scientific reports / Sci Rep. 2021 Dec 30;11(1):24503. doi: 10.1038/s41598-021-04279-4.
2021
AOU San Luigi di Orbassano
Novello S; Terzolo M; Paola B; Gianetta M; Bianco V; Arizio F; Brero D; Perini AME; Boccuzzi A; Caramello V; Perboni A; Bellavia F; Scagliotti GV;
Descriptive Comparative Analysis of Patients With Cancer Referring to the Emergency Department of an Italian University Hospital Across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves. in JCO oncology practice / JCO Oncol Pract. 2021 Dec;17(12):e1887-e1894. doi: 10.1200/OP.21.00098. Epub 2021 Jul 6.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Passiglia F; Capelletto E; Boccuzzi A; Caramello V; Olmetto E; Persano I; De Filippis M; Pisano C; Bironzo P; Mariniello A; Di Maio M; Novello S;
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon. in Cancer treatment reviews / Cancer Treat Rev. 2021 Dec;101:102308. doi: 10.1016/j.ctrv.2021.102308. Epub 2021 Oct 18.
2021
AOU San Luigi di Orbassano
Passiglia F; Bertaglia V; Reale ML; Delcuratolo MD; Tabbò F; Olmetto E; Capelletto E; Bironzo P; Novello S;
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Aug 10;39(23):2574-2585. doi: 10.1200/JCO.20.02574. Epub 2021 Jun 2.
2021
AOU San Luigi di Orbassano
Passiglia F; Cinquini M; Bertolaccini L; Del Re M; Facchinetti F; Ferrara R; Franchina T; Larici AR; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Novello S;
Exploring the role of respiratory microbiome in lung cancer: A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Aug;164:103404. doi: 10.1016/j.critrevonc.2021.103404. Epub 2021 Jun 29
2021
ASL Asti
AOU San Luigi di Orbassano
Novello S; Galetta D; Menis J; Tiseo M; Facchinetti F; Bironzo P; Sartori G; Russano M; Rinaldi S; Prelaj A; Pignataro D; Montrone M; Meacci F; Bianconi M; Di Noia V; Mazzotta M; Pilotto S; Perrone F; Belluomini L;
Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042. in JTO clinical and research reports / JTO Clin Res Rep. 2021 Jul 1;2(8):100205. doi: 10.1016/j.jtocrr.2021.100205. eCollection 2021 Aug.
2021
AOU San Luigi di Orbassano
Mansfield AS; Herbst RS; de Castro G Jr; Hui R; Peled N; Kim DW; Novello S; Satouchi M; Wu YL; Garon EB; Reck M; Robinson AG; Samkari A; Piperdi B; Ebiana V; Lin J; Mok TSK;
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Apr;160:103300. doi: 10.1016/j.critrevonc.2021.103300. Epub 2021 Mar 17
2021
AOU San Luigi di Orbassano
De Luca C; Russo G; Reale ML; Tabbò F; Belluomini L; Bironzo P; Listì A; Righi L; Pisapia P; Pepe F; Passiglia F; Pilotto S; Malapelle U; Novello S; Troncone G;
Current treatment and future challenges in ROS1- and ALK-rearranged advanced non-small cell lung cancer. in Cancer treatment reviews / Cancer Treat Rev. 2021 Apr;95:102178. doi: 10.1016/j.ctrv.2021.102178. Epub 2021 Mar 10.
2021
AOU San Luigi di Orbassano
Passiglia F; Novello S; Pignataro D; Remon J;
Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon? in ImmunoTargets and therapy / Immunotargets Ther. 2021 Feb 5;10:9-26. doi: 10.2147/ITT.S253581. eCollection 2021.
2021
AOU San Luigi di Orbassano
Novello S; Cetoretta V; Reale ML; Passiglia F;
PS01.04 International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results in Journal of Thoracic Oncology
2021
AO Cuneo
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Scagliotti G; Porcu L; Arizio F; Spatafora M; Righi L; Torri V; Wiest GH; Sotoparra H; Schumann C; Valmadre G; Borra G; Schena M; Morabito A; Santo A; Chiari R; Gregorc V; Reck M; Manegold C; Griesinger F; Follador A; Ferrari A; Bearz A; Caffo O; Irtelli L; Dickgreber N; Cecere F; Schutte W; Stoelben E; Geissler M; et alii...
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis. in Cancer treatment and research communications / Cancer Treat Res Commun. 2021;27:100378. doi: 10.1016/j.ctarc.2021.100378. Epub 2021 Apr 19.
2021
AOU San Luigi di Orbassano
Frimodt-Moller B; Zimmermann AH; Fabre E; Alonso Garcia M; Moro-Sibilot D; Nadal E; Nakagawa K; Garon EB; Novello S; Ponce Aix S; Visseren-Grul CM; Reck M;
FP13.01 5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1–Positive Advanced NSCLC in Journal of Thoracic Oncology
2021
AOU San Luigi di Orbassano
Herbst R; Garon E; Kim D; Cho BC; Gervais R; Perez-Gracia JL; Han J; Majem M; Forster MD; Monnet I; Novello S; Gubens MA; Boyer M; Su W; Samkari A; Jensen EH; Piperdi B; Baas P;
Patients With Lung Cancer and Coronavirus Disease 2019 Epidemic: An Experience From an Italian University Hospital. in JTO clinical and research reports / JTO Clin Res Rep. 2020 Sep;1(3):100067. doi: 10.1016/j.jtocrr.2020.100067. Epub 2020 Jun 5.
2020
AOU San Luigi di Orbassano
Perboni A; Boccuzzi A; Veltri A; Novello S; Scagliotti G; Terzolo M;
KRAS inhibition in non-small cell lung cancer: Past failures, new findings and upcoming challenges. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Sep;137:57-68. doi: 10.1016/j.ejca.2020.06.023. Epub 2020 Jul 31.
2020
AOU San Luigi di Orbassano
Troncone G; Danesi R; Furlan D; Pagni F; Righi L; Del Re M; Malapelle U; Passiglia F; Novello S;
Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Oct;9(5):1724-1727. doi: 10.21037/tlcr-20-545.
2020
AOU San Luigi di Orbassano
Novello S; Reale ML; Tabbò F;
An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease. in Respirology (Carlton, Vic.) / Respirology. 2020 Nov;25 Suppl 2:24-36. doi: 10.1111/resp.13965. Epub 2020 Oct 29.
2020
AOU San Luigi di Orbassano
Novello S; Reale ML; Rigney M; Vavalà T; King JC;
(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival. in Cancers / Cancers (Basel). 2020 May 5;12(5):1163. doi: 10.3390/cancers12051163.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Veltri A; Novello S; Arena V; Racca M; Scapoli P; Liberini V; Passera R; Gallio E; Rampado O; Reale ML; Bertaglia V; Ceci F; Polverari G; Deandreis D;
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1505-1517. doi: 10.1200/JCO.19.03136. Epub 2020 Mar 9.
2020
AOU San Luigi di Orbassano
Novello S; Rubio-Viqueira B; Garon EB; Reck M; Jennens RR; Grossi F; Peled N; Bischoff HG; Cheng SY; Powell SF; Clingan P; Hochmair MJ; Hui R; Dómine M; Felip E; Esteban E; Speranza G; Gadgeel S; Rodríguez-Abreu D; Boyer M; Kurata T; Gray JE; Yang J; Bas T; Pietanza MC; Garassino MC;
Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1?Positive, Advanced Non?Small-Cell Lung Cancer in the KEYNOTE-010 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1580-1590. doi: 10.1200/JCO.19.02446. Epub 2020 Feb 20.
2020
AOU San Luigi di Orbassano
Gubens MA; Su WC; Szalai Z; Novello S; Monnet I; Forster MD; Majem M; Arvis CD; Han JY; Perez-Gracia JL; Cho BC; Kim DW; Garon EB; Herbst RS; Ceresoli GL; Samkari A; Jensen EH; Lubiniecki GM; Baas P;
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
ASL Città di Torino
Banna GL; Camisa R; Di Maio M; Rossi G; Rossi A; Cortinovis DL; Bria E; Novello S; Baldessari C; Bartoli G; Pizzutilo EG; Landi L; Toschi L; Dall'Olio FG; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Camerini A; Bearz A; Sala E; Cerea G; Migliorino MR; Bennati C; Ardizzoni A; Vita E; Rossi S; et alii...
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 May;31(5):609-618. doi: 10.1016/j.annonc.2020.02.006. Epub 2020 Feb 20.
2020
AOU San Luigi di Orbassano
McCleod M; Park K; Soo R; Takeda Y; Marquez-Medina D; Novello S; Mandziuk S; Sugawara S; Fischer JR; Orlov S; Reinmuth N; Planchard D; Geater SL; Powell M; May R; Scheuring U; Stockman P; Kowalski D;
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Mar;22(3):294-301. doi: 10.1007/s12094-019-02222-8. Epub 2019 Oct 19.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
AO Ordine Mauriziano
Novello S; Tiseo M; Di Maio M; Galetta D; Bria E; Rossi G; Cortinovis D; Rizzo P; Tabbò F; Delmonte A; Bareggi C; Sergi C; Del Conte A; Graziano P; Gregorc V; Casartelli C; Rossi A; Borra G; Maiello E; Martelli O; Scotti V; Riccardi F; Cecere F; Cappuzzo F; Pilotto S; Osman G; Ghilardi L; Pizzutillo P; Bordi P; et alii...
New emerging targets in cancer immunotherapy: the role of VISTA. in ESMO open / ESMO Open. 2020 Jun;4(Suppl 3):e000683. doi: 10.1136/esmoopen-2020-000683.
2020
AOU San Luigi di Orbassano
Novello S; Bironzo P; Tagliamento M;
Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jun;144:76-84. doi: 10.1016/j.lungcan.2020.04.009. Epub 2020 Apr 20.
2020
AOU San Luigi di Orbassano
Radonjic D; Gottfried M; Novello S; Reck M; Corral J; Grohé C; Popat S; Kaiser R;
Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience. in Journal of thoracic disease / J Thorac Dis. 2020 Jul;12(7):3877-3882. doi: 10.21037/jtd.2020.03.76.
2020
AOU San Luigi di Orbassano
Vallone S; Ferraresi F; Passiglia F; Capelletto E; Novello S;
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 Jan 20;38(3):271-280. doi: 10.1200/JCO.19.01348. Epub 2019 Nov 21.
2020
AOU San Luigi di Orbassano
Reddy S; Novello S; Ramlau R; Kato T; Wilson J; Rodríguez-Cid J; Cicin I; Hermes B; Laktionov K; Tafreshi A; Vicente D; Luft A; Kowalski D; Mazieres J; Kopp HG; Piperdi B; Li X; Burke T; Paz-Ares L;
Wnt/IL-1?/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5. in International journal of cancer / Int J Cancer. 2020 Jan 1;146(1):192-207. doi: 10.1002/ijc.32419. Epub 2019 Jun 4.
2020
AOU San Luigi di Orbassano
Riganti C; Novello S; Bussolino F; Righi L; Alexa-Stratulat T; Comunanza V; Grosso F; Tabbò F; Ananthanarayanan P; Bironzo P; Orecchia S; Napoli F; Izzo S; Libener R; Scagliotti GV; Salaroglio IC; Kopecka J; Milosevic V;
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jan;139:47-54. doi: 10.1016/j.lungcan.2019.10.022. Epub 2019 Oct 31.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Di Maio M; Perrone F; Novello S; Scagliotti GV; Aglietta M; Bironzo P; Sonetto C; La Salvia A; Muratori L; Trevisi E; Leone G; Mariniello A; Di Stefano RF; Pignataro D; Ghisoni E; Zichi C; Marandino L; Lombardi P; De Luca E; Reale ML;
Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jan;139:216-218. doi: 10.1016/j.lungcan.2019.11.005. Epub 2019 Nov 13.
2020
AOU San Luigi di Orbassano
Besse B; Dingemans AC; Levy A; Novello S; Hendriks LE; Berghmans T; Giaj Levra M; Giaj-Levra N;
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102877. doi: 10.1016/j.critrevonc.2020.102877. Epub 2020 Jan 18
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Perrone F; Scagliotti GV; Aglietta M; Novello S; Leone F; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; De Luca E; Zichi C; Marandino L; Lombardi P; Di Maio M;
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Feb;140:71-79. doi: 10.1016/j.lungcan.2019.12.006. Epub 2019 Dec 16.
2020
AOU San Luigi di Orbassano
ASL Città di Torino
ASL Torino 4
AOU Alessandria
AOU Novara
Novello S; Rossi A; Ferrari S; Zullo A; Carta A; Vattemi E; Pagano M; Gelibter A; Martelli O; Pino MS; Cecere F; Berardi R; Migliorino MR; Tonini G; Galetta D; Sergi C; Nonnis D; Verderame F; Del Conte A; Scotti V; Borra G; Piovano PL; Ceresoli GL; Finocchiaro G; Romano GD; Cortinovis D; Vitiello F; Tiseo M; Barbieri F; et alii...
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102858. doi: 10.1016/j.critrevonc.2019.102858. Epub 2019 Dec 28
2020
AOU San Luigi di Orbassano
Rossi G; Ramella S; Passaro A; Menis J; Malapelle U; Franchina T; Ferrara R; Del Re M; Bertolaccini L; Facchinetti F; Pilotto S; Passiglia F; Trisolini R; Novello S;
Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?-a literature review. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2674-2685. doi: 10.21037/tlcr-20-710.
2020
AOU San Luigi di Orbassano
Novello S; Bertaglia V; Bironzo P; Passiglia F; Leone G;
Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2518-2520. doi: 10.21037/tlcr-2019-cnsclc-14.
2020
AOU San Luigi di Orbassano
Novello S; Passiglia F;
Double immune checkpoint blockade in advanced NSCLC. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102980. doi: 10.1016/j.critrevonc.2020.102980. Epub 2020 May 19
2020
AOU San Luigi di Orbassano
Scagliotti GV; Novello S; Mariniello A; Ramalingam SS;
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Apr;148:102862. doi: 10.1016/j.critrevonc.2019.102862. Epub 2020 Jan 25
2020
AOU San Luigi di Orbassano
Rossi G; Ramella S; Pilotto S; Passaro A; Menis J; Franchina T; Malapelle U; Ferrara R; Facchinetti F; Del Re M; Passiglia F; Bertolaccini L; Trisolini R; Novello S;
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Jul 20;12:1758835920915983. doi: 10.1177/1758835920915983. eCollection 2020
2020
AOU San Luigi di Orbassano
AO Cuneo
Grossi F; Colantonio I; Roila F; Novello S; Macerelli M; Garassino MC; Tognetto M; Mandruzzato M; Grilli G; Chella A; Cecere FL; Pasello G; Rocco D; Tiseo M; Lamberti G; Gelsomino F; Fiorentino M; Ardizzoni A;
Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure? in Annals of translational medicine / Ann Transl Med. 2019 Sep;7(Suppl 6):S212. doi: 10.21037/atm.2019.08.91.
2019
AOU San Luigi di Orbassano
Novello S; Passiglia F; Bironzo P;
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2019 Oct;17(5):332-347.e2. doi: 10.1016/j.clgc.2019.07.007. Epub 2019 Jul 20
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Novello S; Aglietta M; Tucci M; Buttigliero C; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; Lombardi P; Zichi C; De Luca E; Marandino L; Scagliotti GV; Perrone F; Di Maio M;
Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2019 Oct;136:145-147. doi: 10.1016/j.lungcan.2019.08.007. Epub 2019 Aug 13.
2019
AOU San Luigi di Orbassano
Reck M; Berghmans T; Hasan B; Novello S; Dingemans AC; Besse B; Falk S; Le Péchoux C; Hendriks LEL; Levy A; Faivre-Finn C;
Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional Report. in In vivo (Athens, Greece) / In Vivo. 2019 Nov-Dec;33(6):2021-2026. doi: 10.21873/invivo.11699.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Valabrega G; DI Maio M; Zichi C; Giajlevra M; Parra HS; Gelibter A; Cecere F; Barbieri F; Del Conte A; Chiari R; Righi L; Catino A; Novello S; Ghisoni E; Mariniello A;
Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ?1% by the USA Food and Drug Administration. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2019 Nov 1;30(11):1686-1688. doi: 10.1093/annonc/mdz295.
2019
AOU San Luigi di Orbassano
Tan D; Rolfo C; Reck M; Pennell NA; Peled N; Liu SV; Dingemans AM; Cufer T; Califano R; Blais N; Novello S; Remon J; Mountzios G; Vansteenkiste J; West H; Besse B;
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Nov;122:109-114. doi: 10.1016/j.ejca.2019.09.012. Epub 2019 Oct 28.
2019
AOU San Luigi di Orbassano
Besse B; Novello S; O'Brien M; Reck M; Edwards J; Lantuéjoul S; Girard N; Greillier L; Pochesci A; Hasan B; GiajLevra N; GiajLevra M; Faivre-Finn C; Berghmans T; Hendriks LEL; Levy A; Dingemans AC;
Third line scenario in advanced non-small cell lung cancer: is the anti-angiogenetic strategy the only actor up to now? in Translational cancer research / Transl Cancer Res. 2019 Mar;8(Suppl 2):S79-S83. doi: 10.21037/tcr.2018.08.23.
2019
AOU San Luigi di Orbassano
Mecca C; Bertaglia V; Novello S;
Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM). in Tumori / Tumori. 2019 Jul;105(5_suppl):3-14. doi: 10.1177/0300891619857418.
2019
AOU San Luigi di Orbassano
Rossi A; Ricardi U; Puma F; Passiglia F; Marchetti A; Inno A; Gasparini S; Delmonte A; Cappuzzo F; Bertolaccini L; Baldini E; Metro G; Pilotto S; Facchinetti F; Crinò L; Novello S;
Corrigendum to "Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario" [Crit. Rev. Oncol./Hematol. 122 (February) (2018) 150-156]. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:158. doi: 10.1016/j.critrevonc.2018.06.018. Epub 2018 Nov 2.
2019
AOU San Luigi di Orbassano
Buffoni L; Novello S; Robinson T; Tabbò F; Addeo A;
A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Jan;14(1):130-134. doi: 10.1016/j.jtho.2018.08.2028. Epub 2018 Sep 11.
2019
AOU San Luigi di Orbassano
Toffart AC; Osman G; Girard N; Gervais R; Letreut J; Poudenx M; Westeel V; Chiari R; Rossi G; Mazieres J; Antoine M; Brevet M; Ferrer L; Giaj Levra M; Novello S; Moro-Sibilot D;
Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer. in Translational cancer research / Transl Cancer Res. 2019 Jan;8(Suppl 1):S48-S54. doi: 10.21037/tcr.2018.10.23.
2019
ASL Cuneo 1
AOU San Luigi di Orbassano
Novello S; Vavalà T; Mariniello A;
Lung Cancer in Italy. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Dec;14(12):2046-2052. doi: 10.1016/j.jtho.2019.05.019.
2019
AOU San Luigi di Orbassano
Trisolini R; Ramella S; Mangone L; Malapelle U; Guerrera F; Passiglia F; Calandri M; Novello S;
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Dec;123:28-35. doi: 10.1016/j.ejca.2019.09.013. Epub 2019 Oct 23.
2019
AOU San Luigi di Orbassano
Vansteenkiste J; Besse B; Giaj Levra N; Giaj Levra M; Hasan B; De Ruysscher D; Levy A; Novello S; Berghmans T; Dooms C; Hendriks LEL; Dingemans AC;
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4.
2019
AOU San Luigi di Orbassano
Au KH; Moro-Sibilot D; Shih JY; Yoh K; Imamura F; Nadal E; Novello S; Park K; Chiu CH; Paz-Ares L; Ponce Aix S; Nishio M; Seto T; Garon EB; Nakagawa K; Enatsu S; Zimmermann A; Frimodt-Moller B; Visseren-Grul C; Reck M;
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Dec;14(12):2109-2119. doi: 10.1016/j.jtho.2019.07.025. Epub 2019 Aug 6.
2019
AOU San Luigi di Orbassano
Peters S; Porta RR; Infante M; Dziadziuszko R; Gietema H; Cufer T; Ekman S; McDonald F; Paz-Ares L; Guckenberger M; Senan S; Scagliotti GV; Peled N; Gaga M; Lievens Y; Ramella S; Postmus PE; Van Schil P; Smit EF; Reck M; O'Brien M; Edwards J; Lantuéjoul S; Greillier L; Girard N; Giaj-Levra N; Giaj-Levra M; Faivre-Finn C; Hasan B; et alii...
Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Dec;14(12):2053-2061. doi: 10.1016/j.jtho.2019.05.037. Epub 2019 Jun 11.
2019
AOU San Luigi di Orbassano
Dingemans AC; Levy A; Hasan B; Hendriks LE; Novello S; Besse B; Durieux V; Giaj-Levra M; Giaj-Levra N; Berghmans T;
Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Aug;14(8):1458-1471. doi: 10.1016/j.jtho.2019.03.029. Epub 2019 May 9.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Papotti M; Di Maio M; Novello S; Righi L; Bussolino F; Ruffini E; Ardissone F; Comunanza V; Passone E; Cartia CF; Tabbò F; Bironzo P; Milosevic V; Ananthanarayanan P; Gagliasso M; Costardi L; Maletta F; Pradotto M; Salaroglio IC; Kopecka J; Napoli F; Scagliotti GV; Riganti C;
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2019 Aug;134:210-217. doi: 10.1016/j.lungcan.2019.06.028. Epub 2019 Jun 27.
2019
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
Novello S; Migliaretti G; Pacchiana MV; Stura I; Critelli R; Metro G; Morelli AM; Manzo A; Ricciardi S; Bria E; Colantonio I; Ciuffreda L; Pisconti S; Ceresoli GL; Del Conte A; Gregorc V; Scotti V; Galetta D; Romano G; Grossi F; Delmonte A; Costanzo FD; Tiseo M; Chiari R; Morabito A; Capelletto E; Migliorino MR;
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach. in PloS one / PLoS One. 2019 Nov 13;14(11):e0224027. doi: 10.1371/journal.pone.0224027. eCollection 2019.
2019
AOU San Luigi di Orbassano
Taraborrelli M; Paci M; Tiseo M; Botti A; Bria E; Baldini E; Vagge S; Banna G; Perna M; Capelletto E; Franceschini D; Borghetti P; Greco C; Greco S; Grossi F; Bonti V; Ferrari K; Maragna V; Ciammella P; Giaj-Levra N; Bruni A; Poletti V; Granone P; Ricardi U; Novello S; Scotti V;
The elderly patient individualized chemotherapy (EPIC) trial, a study for an aged population of non-small cell lung cancer in Annals of Oncology
2019
AOU San Luigi di Orbassano
Passiglia F; Capelletto E; Grossi F; Bidoli P; Galetta D; Follador A; Valmadre GP; Defferrari C; Caffo O; Bearz A; Colantonio I; Gregorc V; Scotti V; Cognetti F; Cordero L; Arizio F; Novello S; Torri V; Scagliotti G;
PD-1 is intrinsically expressed by lung cancer cells with stemness features inhibited by PD-1 blockade in Cancer Research
2019
AOU San Luigi di Orbassano
Rotolo R; Leuci V; Donini C; Sanlorenzo M; Vujic I; Medico G; Vita F; Gammaitoni L; Righi L; Riganti C; Vigna E; D'Ambrosio L; Grignani G; Scagliotti GV; Novello S; Aglietta M; Sangiolo D;
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.
2018
AOU San Luigi di Orbassano
Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;
NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung Cancer. in The oncologist / Oncologist. 2018 Oct;23(10):1133-e112. doi: 10.1634/theoncologist.2018-0292. Epub 2018 Aug 3.
2018
AOU San Luigi di Orbassano
Gregorc V; Cavina R; Novello S; Grossi F; Lazzari C; Capelletto E; Genova C; Salini G; Lambiase A; Santoro A;
Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Nov;13(11):1750-1761. doi: 10.1016/j.jtho.2018.07.002. Epub 2018 Jul 7.
2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Pezzuto F; Punzi A; Pennella A; Pasello G; Papanikolaou N; Marzullo A; Novello S; Maiorano E; Lunardi F; De Palma A; Fusco N; Cavone D; Catino AM; Capelletto E; Barbieri F; Harari S; Albini A; Sonzogni A; Maisonneuve P; Kern I; Calabrese F; Bosari S; Ferrero S; Rossi G; Righi L; Papotti M; Pelosi G; Serio G; Scattone A; et alii...
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. in The New England journal of medicine / N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16.
2018
AOU San Luigi di Orbassano
Gandhi L; Rodríguez-Abreu D; Gadgeel S; Esteban E; Felip E; De Angelis F; Domine M; Clingan P; Hochmair MJ; Powell SF; Cheng SY; Bischoff HG; Peled N; Grossi F; Jennens RR; Reck M; Hui R; Garon EB; Boyer M; Rubio-Viqueira B; Novello S; Kurata T; Gray JE; Vida J; Wei Z; Yang J; Raftopoulos H; Pietanza MC; Garassino MC; et alii...
Immunotherapy & thoracic cancers. in Journal of thoracic disease / J Thorac Dis. 2018 May;10(Suppl 13):S1425-S1426. doi: 10.21037/jtd.2017.12.137.
2018
AOU San Luigi di Orbassano
Rossi A; Novello S;
The Tradition of the Rising Sun: When Geography Counts. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 May;13(5):598-600. doi: 10.1016/j.jtho.2018.03.006.
2018
AOU San Luigi di Orbassano
Rossi A; Novello S;
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. in Clinical lung cancer / Clin Lung Cancer. 2018 Mar;19(2):191-198. doi: 10.1016/j.cllc.2017.10.012. Epub 2017 Oct 28.
2018
AOU San Luigi di Orbassano
Gobbini E; Pilotto S; Pasello G; Polo V; Di Maio M; Arizio F; Galetta D; Petrillo P; Chiari R; Matocci R; Di Costanzo A; Di Stefano TS; Aglietta M; Cagnazzo C; Sperduti I; Bria E; Novello S;
Loss of C/EBP-? LIP drives cisplatin resistance in malignant pleural mesothelioma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Rubinstein M; Novello S; Di Maio M; Napoli F; Pradotto M; Capelletto E; Ricci L; Ananthanarayanan P; Milosevic V; Grosso F; Libener R; Orecchia S; Salaroglio IC; Righi L; Kopecka J; Scagliotti GV; Riganti C;
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2018 Jun;19(6):799-811. doi: 10.1016/S1470-2045(18)30193-1. Epub 2018 May 9.
2018
AOU San Luigi di Orbassano
ASL Alessandria
Bearz A; Muzio A; Novello S; Taylor P; Shah R; Tiseo M; Bidoli P; Polychronis A; Jassem J; Grossi F; Favaretto A; Gaafar RM; Gregorc V; Lambiase A; O'Brien M; Greillier L; Fontana F; Salini G;
Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2018 Jun;26(6):1841-1849. doi: 10.1007/s00520-017-4004-1. Epub 2017 Dec 21.
2018
AOU San Luigi di Orbassano
Carnio S; Galetta D; Scotti V; Cortinovis DL; Antonuzzo A; Pisconti S; Rossi A; Martelli O; Cecere FL; Lunghi A; Del Conte A; Montagna ES; Topulli J; Pelizzoni D; Rapetti SG; Gianetta M; Pacchiana MV; Pegoraro V; Cataldo N; Bria E; Novello S;
Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Jan;13(1):124-133. doi: 10.1016/j.jtho.2017.09.1968. Epub 2017 Oct 24.
2018
AOU San Luigi di Orbassano
Patil NS; Righi L; Koeppen H; Zou W; Izzo S; Grosso F; Libener R; Loiacono M; Monica V; Buttigliero C; Novello S; Hegde PS; Papotti M; Kowanetz M; Scagliotti GV;
Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:150-156. doi: 10.1016/j.critrevonc.2017.12.015. Epub 2017 Dec 3
2018
AOU San Luigi di Orbassano
Addeo A; Tabbò F; Robinson T; Buffoni L; Novello S;
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification. in Nature biotechnology / Nat Biotechnol. 2018 Dec 17. doi: 10.1038/nbt.4313.
2018
AOU San Luigi di Orbassano
Bulik-Sullivan B; Busby J; Palmer CD; Davis MJ; Murphy T; Clark A; Busby M; Duke F; Yang A; Young L; Ojo NC; Caldwell K; Abhyankar J; Boucher T; Hart MG; Makarov V; Montpreville VT; Mercier O; Chan TA; Scagliotti G; Bironzo P; Novello S; Karachaliou N; Rosell R; Anderson I; Gabrail N; Hrom J; Limvarapuss C; Choquette K; et alii...
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Dec 1;29(12):2288-2295. doi: 10.1093/annonc/mdy449.
2018
AOU San Luigi di Orbassano
Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;
Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle? in Annals of translational medicine / Ann Transl Med. 2018 Dec;6(Suppl 2):S120. doi: 10.21037/atm.2018.12.25.
2018
AOU San Luigi di Orbassano
Passiglia F; Novello S;
Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2018 Apr;93:37-46. doi: 10.1016/j.ejca.2018.01.067. Epub 2018 Feb 21.
2018
AOU San Luigi di Orbassano
Levy A; Faivre-Finn C; Hasan B; De Maio E; Berghoff AS; Girard N; Greillier L; Lantuéjoul S; O'Brien M; Reck M; Dingemans AC; Novello S; Berghmans T; Besse B; Hendriks L;
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Apr;13(4):568-575. doi: 10.1016/j.jtho.2017.12.003. Epub 2017 Dec 18.
2018
AOU San Luigi di Orbassano
Pilotto S; Sperduti I; Leuzzi G; Chiappetta M; Mucilli F; Ratto GB; Lococo F; Filosso PL; Spaggiari L; Novello S; Milella M; Santo A; Scarpa A; Infante M; Tortora G; Facciolo F; Bria E;
Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer. in Frontiers in oncology / Front Oncol. 2018 Jul 27;8:278. doi: 10.3389/fonc.2018.00278. eCollection 2018.
2018
ASL Cuneo 1
AOU San Luigi di Orbassano
Novello S; Vavalà T; Morelli AM; Turkaj A;
Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapy. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2018 Aug 3;10:1758835918789364. doi: 10.1177/1758835918789364. eCollection 2018.
2018
ASL Cuneo 1
AOU San Luigi di Orbassano
Vavalà T; Novello S;
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysis. in ESMO open / ESMO Open. 2018 Nov 1;3(6):e000327. doi: 10.1136/esmoopen-2018-000327. eCollection 2018.
2018
AOU San Luigi di Orbassano
Garassino MC; Kawaguchi T; Gregorc V; Rulli E; Ando M; Marsoni S; Isa SI; Novello S; Farina G; Barni S; Torri V; Cinquini M;
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. in Oncoimmunology / Oncoimmunology. 2017 Nov 27;7(3):e1398874. doi: 10.1080/2162402X.2017.1398874. eCollection 2018.
2018
AOU San Luigi di Orbassano
Bussolino F; Comunanza V; Bironzo P; Orecchia S; Libener R; Pradotto M; Kopecka J; Picca F; Oddo D; Morena D; Falcomatà C; Righi L; Salaroglio IC; Lingua MF; Riganti C; Novello S; Scagliotti GV; Di Nicolantonio F; Taulli R;
Lung cancer in women: Etiopathogenesis, clinical presentation and treatment response in Rassegna di Patologia dell'Apparato Respiratorio
2018
ASL Cuneo 1
AOU San Luigi di Orbassano
Bironzo P; Vavalà T; Novello S;
Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 Sep;111:30-37. doi: 10.1016/j.lungcan.2017.06.009. Epub 2017 Jun 16.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AO Ordine Mauriziano
Novello S; Bordi P; Catino A; Pisconti S; Cortinovis D; Franchina T; Migliorino MR; Delmonte A; Buffoni L; Ceribelli A; Scotti V; Riccardi F; Gregorc V; Di Maio M; Rossi G; Bria E; Rossi A; Graziano P; Tiseo M; Galetta D; Gobbini E; Maiello E; Arizio F;
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613. in Clinical lung cancer / Clin Lung Cancer. 2017 Sep;18(5):583-588. doi: 10.1016/j.cllc.2017.02.005. Epub 2017 Mar 1.
2017
AOU San Luigi di Orbassano
Remon J; Menis J; Hasan B; Peric A; De Maio E; Novello S; Reck M; Berghmans T; Wasag B; Besse B; Dziadziuszko R;
Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 May;107:84-90. doi: 10.1016/j.lungcan.2016.05.021. Epub 2016 May 31.
2017
AOU San Luigi di Orbassano
Vavalà T; Monica V; Lo Iacono M; Mele T; Busso S; Righi L; Papotti M; Scagliotti GV; Novello S;
Helical-Tip Needle for Transthoracic Percutaneous Image-Guided Biopsy of Lung Tumors: Results of a Pilot Prospective Comparative Study with a Standard Tru-Cut Needle. in Cardiovascular and interventional radiology / Cardiovasc Intervent Radiol. 2017 Jun;40(6):930-936. doi: 10.1007/s00270-017-1585-5. Epub 2017 Jan 2
2017
AOU San Luigi di Orbassano
Veltri A; Busso M; Sardo D; Angelino V; Priola AM; Novello S; Barba M; Gatti G; Righi L;
Interview: developing therapies for lung cancer. in Lung cancer management / Lung Cancer Manag. 2017 Jul;6(1):25-27. doi: 10.2217/lmt-2017-0007. Epub 2017 Jul 14.
2017
AOU San Luigi di Orbassano
Novello S;
Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic cases. in Thoracic cancer / Thorac Cancer. 2017 Jul;8(4):359-362. doi: 10.1111/1759-7714.12416. Epub 2017 Apr 6.
2017
AOU San Luigi di Orbassano
Mengoli MC; Orsi G; Lococo F; Grizzi G; Barbieri F; Bertolini F; Rossi G; Novello S;
Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysis. in Clinical lung cancer / Clin Lung Cancer. 2017 Jan;18(1):23-33.e1. doi: 10.1016/j.cllc.2016.08.006. Epub 2016 Oct 28.
2017
AOU San Luigi di Orbassano
La Salvia A; Rossi A; Galetta D; Gobbini E; De Luca E; Novello S; Di Maio M;
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer. in Clinical lung cancer / Clin Lung Cancer. 2017 Jan;18(1):50-59. doi: 10.1016/j.cllc.2016.09.013. Epub 2016 Oct 19.
2017
AOU San Luigi di Orbassano
Wakelee H; Zvirbule Z; De Braud F; Kingsley CD; Mekhail T; Lowe T; Schütte W; Lena H; Lawler W; Braiteh F; Cosgriff T; Kaen D; Boyer M; Hsu J; Phan S; Novello S;
Advanced squamous lung cancer: therapeutic options, future directions, unmet needs and results of a monocentric survey. in Lung cancer management / Lung Cancer Manag. 2017 Dec;6(3):93-107. doi: 10.2217/lmt-2017-0011. Epub 2017 Dec 1.
2017
AOU San Luigi di Orbassano
Bertaglia V; Vallone S; Pacchiana MV; Novello S;
P1.04-002 Tolerability of Osimertinib and Its Impact on Quality of Life in Advanced Non-Small Cell Lung Cancer Patients: The ARPA Study in Journal of Thoracic Oncology
2017
AOU San Luigi di Orbassano
Capelletto E; Pacchiana MV; De Luca E; Reale ML; Gianetta M; Novello S;
Results of an integrated multi-platforms analysis in squamous cell lung carcinoma (SqCLC) revealed PI3K/RICTOR-mTORC2 axis as a potential prognostic biomarker and druggable target in Annals of Oncology
2017
AOU San Luigi di Orbassano
Pilotto S; Simbolo M; Gkountakos A; Mafficini A; Vicentini C; Sperduti I; Ludovini V; Chiari R; Novello S; Milella M; Carbognin L; Caregnato E; Santo A; Infante M; Brunelli M; Corbo V; Scarpa A; Tortora G; Bria E;
Results of an integrated multi-platforms analysis in squamous cell lung carcinoma (SqCLC) revealed PI3K/RICTOR-mTORC2 axis as a potential prognostic biomarker and druggable target in Annals of oncology : official journal of the European Society for Medical Oncology
2017
AOU San Luigi di Orbassano
Pilotto S; Simbolo M; Gkountakos A; Mafficini A; Vicentini C; Sperduti I; Ludovini V; Chiari R; Novello S; Milella M; Carbognin L; Caregnato E; Santo A; Infante M; Brunelli M; Corbo V; Scarpa A; Tortora G; Bria E;
Tolerability of osimertinib and its impact on quality of life in advanced non-small cell lung cancer patients: The ARPA study in Journal of Thoracic Oncology
2017
AOU San Luigi di Orbassano
Capelletto E; Pacchiana MV; De Luca E; Reale ML; Gianetta M; Novello S;
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Sep;27(suppl 5):v1-v27. doi: 10.1093/annonc/mdw326.
2016
AOU San Luigi di Orbassano
Novello S; Barlesi F; Califano R; Cufer T; Ekman S; Levra MG; Kerr K; Popat S; Reck M; Senan S; Simo GV; Vansteenkiste J; Peters S;
Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward? in Current treatment options in oncology / Curr Treat Options Oncol. 2016 Oct;17(10):54. doi: 10.1007/s11864-016-0429-x.
2016
ASL Cuneo 1
AOU San Luigi di Orbassano
Novello S; Vavalà T; Buffoni L;
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer. in Investigational new drugs / Invest New Drugs. 2016 Oct;34(5):625-35. doi: 10.1007/s10637-016-0368-1. Epub 2016 Jun 27.
2016
AOU San Luigi di Orbassano
Scagliotti G; Kang JH; Smith D; Rosenberg R; Park K; Kim SW; Su WC; Boyd TE; Richards DA; Novello S; Hynes SM; Myrand SP; Lin J; Smyth EN; Wijayawardana S; Lin AB; Pinder-Schenck M;
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2016 May;95:73-81. doi: 10.1016/j.lungcan.2016.02.011. Epub 2016 Feb 26.
2016
AOU San Luigi di Orbassano
AOU Alessandria
Rossi A; Spitaleri G; Bria E; Cecere F; Rijavec E; Rizzo E; Barbieri F; Menis J; Filipazzi V; Mucciarini C; Genestreti G; Bearz A; Barzelloni ML; Ardizzoia A; Banna GL; Casartelli C; Zilembo N; Cortinovis D; Piovano PL; Caffo O; Novello S; Martelli O; Di Maio M; Morabito A; Vavalà T; Follador A; Tiseo M; Galetta D;
Tackling ALK in non-small cell lung cancer: the role of novel inhibitors. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Jun;5(3):301-21. doi: 10.21037/tlcr.2016.06.10.
2016
AOU San Luigi di Orbassano
Facchinetti F; Tiseo M; Di Maio M; Graziano P; Bria E; Rossi G; Novello S;
Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2016 Dec;5(6):610-627. doi: 10.21037/tlcr.2016.09.03.
2016
AOU San Luigi di Orbassano
Buttigliero C; Bertaglia V; Novello S;
Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2016 Apr;11(4):504-15. doi: 10.1016/j.jtho.2016.01.004. Epub 2016 Jan 13.
2016
AOU San Luigi di Orbassano
Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M;
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study. in Targeted oncology / Target Oncol. 2016 Apr;11(2):157-66. doi: 10.1007/s11523-015-0383-8.
2016
AOU San Luigi di Orbassano
Vatrano S; Righi L; Vavalá T; Rapa I; Busso M; Izzo S; Cappia S; Veltri A; Papotti M; Scagliotti GV; Novello S;
Fatigue in lung cancer patients: symptom burden and management of challenges. in Lung Cancer (Auckland, N.Z.) / Lung Cancer (Auckl). 2016 May 9;7:73-82. doi: 10.2147/LCTT.S85334. eCollection 2016.
2016
AOU San Luigi di Orbassano
Carnio S; Di Stefano RF; Novello S;
Randomized, double-blind, placebo-controlled trial of evofosfamide (Evo) and pemetrexed (Pem) in advanced non-squamous non-small cell lung cancer (n-s NSCLC) in Journal of Clinical Oncology
2016
AOU San Luigi di Orbassano
Csõszi T; Goldman JW; Szilasi M; Von Pawel J; Novello S; Carter CA; Ciuleanu T-E; Del Conte A; Chatta G; Schenker M; Robert F; Orlov S; Zajda K; De Marinis F; Bennett CL; Kroll S; Pearce TE; Belani C;
2016
AOU San Luigi di Orbassano
Yang JC-H; Popat S; Novello S; Groen HJM; Perol M; Felip E; Griesinger F; Reckamp KL; Lee J-S; Smit EF; Blakely CM; Akerley WL; Kim Y-C; Bazhenova L; Califano R; Delmar Hall R; Georgiou P; Isaacson JD; Golsorkhi T; Wakelee HA;
A pivotal randomized phase II study of anetumab ravtansine or vinorelbine in patients with advanced or metastatic pleural mesothelioma after progression on platinum/pemetrexed-based chemotherapy (NCT02610140) in Journal of Clinical Oncology
2016
AOU San Luigi di Orbassano
Hassan R; Jennens R; Van Meerbeeck JP; Nemunaitis JJ; Blumenschein GR; Fennell DA; Kindler HL; Novello S; Elbi C; Walter A; Serpico D; Siegel JM; Childs BH;
A randomized, placebo-controlled study of amatuximab in combination with pemetrexed and cisplatin (P/C) as front-line therapy for subjects with malignant pleural mesothelioma (MPM) in Journal of Clinical Oncology
2016
AOU San Luigi di Orbassano
Hassan R; Fennell D; Scherpereel A; Nowak AK; Von Pawel J; Novello S; McLaughlin M; Hoffman K; Wallin BA;
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2015 Sep;10(9):1341-1348. doi: 10.1097/JTO.0000000000000628.
2015
AOU San Luigi di Orbassano
Pilotto S; Sperduti I; Novello S; Peretti U; Milella M; Facciolo F; Vari S; Leuzzi G; Vavalà T; Marchetti A; Mucilli F; Crinò L; Puma F; Kinspergher S; Santo A; Carbognin L; Brunelli M; Chilosi M; Scarpa A; Tortora G; Bria E;
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Sep;89(3):350-6. doi: 10.1016/j.lungcan.2015.06.019. Epub 2015 Jun 26.
2015
AOU San Luigi di Orbassano
Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S;
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Nov;90(2):234-42. doi: 10.1016/j.lungcan.2015.08.005. Epub 2015 Aug 19.
2015
AOU San Luigi di Orbassano
Barni S; Maiello E; Di Maio M; Ardizzoni A; Cappuzzo F; Maranzano E; Novello S; Bennati C; Ori A; Rizzoli S; Crinò L;
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma. in Oncotarget / Oncotarget. 2015 May 20;6(14):12783-95. doi: 10.18632/oncotarget.3727.
2015
AOU San Luigi di Orbassano
Bria E; Pilotto S; Amato E; Fassan M; Novello S; Peretti U; Vavalà T; Kinspergher S; Righi L; Santo A; Brunelli M; Corbo V; Giglioli E; Sperduti I; Milella M; Chilosi M; Scarpa A; Tortora G;
Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC). in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 May;88(2):160-6. doi: 10.1016/j.lungcan.2015.02.014. Epub 2015 Feb 23.
2015
AOU San Luigi di Orbassano
Garrido P; Engel-Riedel W; Serke M; Giraud P; Ricardi U; Vallejo C; Visseren-Grul C; Ameryckx S; Soldatenkova V; Chouaki N; Novello S;
ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway. in International journal of cancer / Int J Cancer. 2015 Jun 1;136(11):2598-609. doi: 10.1002/ijc.29302. Epub 2014 Nov 12.
2015
AOU San Luigi di Orbassano
Lo Iacono M; Monica V; Vavalà T; Gisabella M; Saviozzi S; Bracco E; Novello S; Papotti M; Scagliotti GV;
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2015 Jun;88(3):319-24. doi: 10.1016/j.lungcan.2015.03.016. Epub 2015 Apr 1.
2015
AOU San Luigi di Orbassano
Buti S; Bordi P; Tiseo M; Bria E; Sperduti I; Di Maio M; Panni S; Novello S; Rapetti SG; Pilotto S; Genestreti G; Rossi A; Pezzuolo D; Camisa R; Tortora G; Ardizzoni A;
Validation of ERCC1 (E1) for response prediction to platinumgemcitabine in Journal of Clinical Oncology
2015
AOU San Luigi di Orbassano
Bepler G; Chen W; Patrick S; Astrow SH; Stephens C; Gandara DR; Rosell R; Ramirez JL; Scagliotti GV; Busso S; Volante M; Novello S;
Individual patients data analysis (IPD) of three randomized studies comparing erlotinib (E) with chemotherapy (CT) in patients with advanced wild-type epidermal growth factor receptor (wtEGFR) non-small cell lung cancer (NSCLC) in Journal of Clinical Oncology
2015
AOU San Luigi di Orbassano
Torri V; Ando M; Rulli E; Floriani IC; Kawaguchi T; Isa S-C; Gregorc V; Novello S; Barni S; Cinquini M; Marsoni S; Farina G; Garassino MC;
"Bad luck" or "science"? This is the dilemma in Rassegna di Patologia dell'Apparato Respiratorio
2015
AOU San Luigi di Orbassano
Novello S;
Management of Italian patients with advanced non-small-cell lung cancer after second-line treatment: results of the longitudinal phase of the LIFE observational study. in Clinical lung cancer / Clin Lung Cancer. 2014 Sep;15(5):338-45.e1. doi: 10.1016/j.cllc.2014.04.004. Epub 2014 May 14.
2014
AOU San Luigi di Orbassano
de Marinis F; Ardizzoni A; Fontanini G; Grossi F; Cappuzzo F; Novello S; Santo A; Lorusso V; Cortinovis D; Iurlaro M; Galetta D; Gridelli C;
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Sep;25(9):1681-1690. doi: 10.1093/annonc/mdu145. Epub 2014 Apr 8.
2014
AOU San Luigi di Orbassano
Kerr KM; Bubendorf L; Edelman MJ; Marchetti A; Mok T; Novello S; O'Byrne K; Stahel R; Peters S; Felip E;
Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2014 Oct;9(10):1540-6. doi: 10.1097/JTO.0000000000000271.
2014
AOU San Luigi di Orbassano
Righi L; Vavalà T; Rapa I; Vatrano S; Giorcelli J; Rossi G; Capelletto E; Novello S; Scagliotti GV; Papotti M;
A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Nov;25(11):2156-2162. doi: 10.1093/annonc/mdu384. Epub 2014 Aug 19.
2014
AOU San Luigi di Orbassano
Novello S; Besse B; Felip E; Barlesi F; Mazieres J; Zalcman G; von Pawel J; Reck M; Cappuzzo F; Ferry D; Carcereny E; Santoro A; Garcia-Ribas I; Scagliotti G; Soria JC;
First-line therapeutic options for advanced non-small-cell lung cancer in the molecular medicine era. in Future oncology (London, England) / Future Oncol. 2014 May;10(6):1081-93. doi: 10.2217/fon.13.247.
2014
AOU San Luigi di Orbassano
Capelletto E; Novello S; Scagliotti GV;
Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2014 May;9(5):733-7. doi: 10.1097/JTO.0000000000000120.
2014
AOU San Luigi di Orbassano
Gridelli C; Novello S; Zilembo N; Luciani A; Favaretto AG; De Marinis F; Genestreti G; Crinò L; Grossi F; Caffo O; Ferraù F; Cruciani G; Brandes AA; Galetta D; Barni S; Fasola G; Cerea G; Ferrari S; Iannacone C; Ciardiello F;
Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the "tolerance" to targeted therapies already available for non-small cell lung cancer treatment in daily clinical practice. in Translational lung cancer research / Transl Lung Cancer Res. 2014 Jun;3(3):173-80. doi: 10.3978/j.issn.2218-6751.2014.06.10.
2014
AOU San Luigi di Orbassano
Novello S; Capelletto E; Cortinovis D; Tiseo M; Galetta D; Valmadre G; Casartelli C; Rapetti SG; Rossi A;
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2014 Jun;15(7):713-21. doi: 10.1016/S1470-2045(14)70162-7. Epub 2014 May 13.
2014
AOU San Luigi di Orbassano
ASL Città di Torino
Gregorc V; Novello S; Lazzari C; Barni S; Aieta M; Mencoboni M; Grossi F; De Pas T; de Marinis F; Bearz A; Floriani I; Torri V; Bulotta A; Cattaneo A; Grigorieva J; Tsypin M; Roder J; Doglioni C; Levra MG; Petrelli F; Foti S; Viganò M; Bachi A; Roder H;
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. in The Lancet. Oncology / Lancet Oncol. 2014 Feb;15(2):143-55. doi: 10.1016/S1470-2045(13)70586-2. Epub 2014 Jan 9.
2014
AOU San Luigi di Orbassano
Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S;
Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2014 Dec;14(12):1495-513. doi: 10.1586/14737140.2014.949245. Epub 2014 S
2014
AOU San Luigi di Orbassano
Carnio S; Novello S; Bironzo P; Scagliotti GV;
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. in Oncotarget / Oncotarget. 2014 Aug 15;5(15):6191-205. doi: 10.18632/oncotarget.2186.
2014
AOU San Luigi di Orbassano
AOU Alessandria
Volante M; Funaro A; Rapa I; Righi L; Ruffini E; Novello S; Orecchia S; Ferrero E; Scagliotti G; Martinetto F; Morone S; Lo Buono N; Ortolan E; Giacomino A;
2nd ESMO Consensus Conference on Lung Cancer: Non-small-cell lung cancer first-line/second and further lines in advanced disease in Annals of Oncology
2014
AOU San Luigi di Orbassano
Besse B; Adjei A; Baas P; Meldgaard P; Nicolson M; Paz-Ares L; Reck M; Smit EF; Syrigos K; Stahel R; Felip E; Peters S; Peters S; Kerr K; Vansteenkiste J; Eberhardt W; Edelman M; Mok T; O'Byrne K; Novello S; Bubendorf L; Marchetti A; Baas P; Reck M; Paz-Ares L; Meldgaard P; Adjei A; Nicolson M; Van Schil P; et alii...
2nd ESMO consensus conference on lung cancer: Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up in Annals of Oncology
2014
AOU San Luigi di Orbassano
Vansteenkiste J; Crinò L; Dooms C; Douillard JY; Faivre-Finn C; Lim E; Rocco G; Senan S; van Schil P; Veronesi G; Stahel R; Peters S; Felip E; Kerr K; Besse B; Eberhardt W; Edelman M; Mok T; O'Byrne K; Novello S; Bubendorf L; Marchetti A; Baas P; Reck M; Syrigos K; Paz-Ares L; Smit E; Meldgaard P; Adjei A; et alii...
Stereotactic ablative radiotherapy (SABR) in non-surgical non small cell lung cancer: Effects on respiratory function in European Respiratory Journal
2014
AOU San Luigi di Orbassano
Ferrero C; Levra MG; Rapetti S; Moretto F; Ricardi U; Filippi A; Ciacco C; Guglielmo M; Focaraccio L; Novello S; Torchio R;
A phase II study of milciclib (PHA-848125AC) in patients (pts) with thymic carcinoma (TC) in Journal of Clinical Oncology
2014
AOU San Luigi di Orbassano
Besse B; Garassino MC; Rajan A; Novello S; Mazieres J; Weiss GJ; Ciomei M; Martignoni M; Petroccione A; Davite C; Giaccone G;
Next-generation sequencing in malignant pleural mesothelioma: A retrospective study in Journal of Clinical Oncology
2014
AOU San Luigi di Orbassano
Scagliotti GV; Iacono ML; Novello S; Libener R; Vatrano S; Righi L; Papotti M; Bironzo P; Monica V; Grosso F;
Final overall survival (OS) results from a phase II study of pemetrexed (Pem) and cisplatin (Cis) with concurrent thoracic radiation (RT) after Pem-Cis induction in patients with unresectable locally advanced (LA) nonsquamous non-small cell lung cancer (NS-NSCLC) in Journal of Clinical Oncology
2014
AOU San Luigi di Orbassano
Novello S; Engel-Riedel W; Serke M; Giraud P; Visseren-Grul C; Ameryckx S; Soldatenkova V; Chouaki N; Garrido P;
Histologic and genotypic re-evaluation of non-small cell lung cancer (NSCLC): A monocentric study in Journal of Clinical Oncology
2014
AOU San Luigi di Orbassano
Vavalá T; Busso M; Righi L; Vatrano S; Cappia S; Sardo D; Rapetti SG; Veltri A; Papotti M; Scagliotti GV; Novello S;
Early response to chemotherapy in patients with non-small-cell lung cancer assessed by [18F]-fluoro-deoxy-D-glucose positron emission tomography and computed tomography. in Clinical lung cancer / Clin Lung Cancer. 2013 May;14(3):230-7. doi: 10.1016/j.cllc.2012.10.004. Epub 2012 Dec 29.
2013
AOU San Luigi di Orbassano
Novello S; Vavalà T; Levra MG; Solitro F; Pelosi E; Veltri A; Scagliotti GV;
MET inhibition in lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2013 Feb;2(1):23-39. doi: 10.3978/j.issn.2218-6751.2012.12.04.
2013
AOU San Luigi di Orbassano
Menis J; Giaj Levra M; Novello S;
Current state-of-the-art therapy for advanced squamous cell lung cancer. in American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting / Am Soc Clin Oncol Educ Book. 2013:354-8. doi: 10.14694/EdBook_AM.2013.33.354.
2013
AOU San Luigi di Orbassano
Scagliotti GV; Novello S; Rapetti S; Papotti M;
High resolution study on survival of pleural mesothelioma from the records of the piedmont registry of malignant mesotheliomas-report on incident cases 2008-2009 in Journal of Thoracic Oncology
2013
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Mirabelli D; Novello S; Ardissone F; Casadio C; Botta M; Piccolini E; Pazé E; Alabiso O; Brentisci C; Gangemi M; Stura A; Biava A; Ruffini E; Guerrera F; Filosso PL; Cappuzzo F; Tiseo M; Chiari R; Landi L; Ricciardi S; Rossi E; Galetta D; Milella M; D'Incecco A; Haspinger ER; Cortinovis D; Santo A; Banna G; Facchinetti F; et alii...
Afatinib in advanced non-small-cell lung cancer in Lung Cancer Management
2013
AOU San Luigi di Orbassano
Di Maio M; Gridelli C; Grossi F; Novello S; De Marinis F;
Tissue biomarker analysis in PROSE, a randomized proteomic stratified phase III study of second line erlotinib (E) versus chemotherapy (CT) in patients with inoperable non-small cell lung cancer (NSCLC) in European Journal of Cancer
2013
AOU San Luigi di Orbassano
Novello S; Barni S; Grossi F; De Pas TM; Mencoboni M; De Marinis F; Roder H; Gregorc V; Hirsh FR; Floriani I;
Phase II study of danusertib (D) in advanced/metastatic non-small cell lung cancers (NSCLC). in Journal of Clinical Oncology
2013
AOU San Luigi di Orbassano
Gauler TC; Besse B; Novello S; Smit EF; Plummer ER; Delord J-P; Nicodemo M; Santoro A; Barone C; Marchetti P; Conte PF; De Jonge MJ; Awada A; Mariani M; Jannuzzo MG; Petroccione A; Ceruti R; Davite C; Eberhardt WEE;
Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2012 Sep;13(5):391-5. doi: 10.1016/j.cllc.2012.01.003. Epub 2012 Mar 21.
2012
AOU San Luigi di Orbassano
Scagliotti GV; Novello S; Schiller JH; Hirsh V; Sequist LV; Soria JC; von Pawel J; Schwartz B; Von Roemeling R; Sandler AB;
Primary pleuropulmonary sarcoma: a rare disease entity. in Clinical lung cancer / Clin Lung Cancer. 2012 Nov;13(6):399-407. doi: 10.1016/j.cllc.2012.05.003. Epub 2012 Jun 5.
2012
AOU San Luigi di Orbassano
Giaj Levra M; Novello S; Scagliotti GV; Papotti M; Le Cesne A;
Role of hormone receptor expression in patients with advanced-stage lung cancer treated with chemotherapy. in Clinical lung cancer / Clin Lung Cancer. 2012 Nov;13(6):416-23. doi: 10.1016/j.cllc.2012.03.006. Epub 2012 Jun 2.
2012
AOU San Luigi di Orbassano
Monica V; Longo M; Felice B; Scagliotti GV; Papotti M; Novello S;
Emerging new agents for the management of patients with non-small cell lung cancer. in Drugs / Drugs. 2012 Jun 19;72 Suppl 1:37-52. doi: 10.2165/1163028-S0-000000000-00000.
2012
AOU San Luigi di Orbassano
Capelletto E; Novello S;
The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors. in Cancer treatment reviews / Cancer Treat Rev. 2012 Jun;38(4):292-302. doi: 10.1016/j.ctrv.2011.07.008. Epub 2011 Sep 9.
2012
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Functional imaging in predicting response to antineoplastic agents and molecular targeted therapies in lung cancer: a review of existing evidence. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2012 Aug;83(2):208-15. doi: 10.1016/j.critrevonc.2011.09.009. Epub 2011 Nov
2012
AOU San Luigi di Orbassano
Novello S; Giaj Levra M; Vavalà T;
Series - Thoracic oncology: Multidisciplinary approach in Rassegna di Patologia dell'Apparato Respiratorio
2012
AOU San Luigi di Orbassano
Novello S;
NGR-hTNF and doxorubicin in relapsed small-cell lung cancer (SCLC) in Journal of Clinical Oncology
2012
AOU San Luigi di Orbassano
Cavina R; Gregorc V; Novello S; Grossi F; Santoro A; Viganò MG; Levra MG; Lambiase A; Bordignon C;
Maintenance therapy in NSCLC: why? To whom? Which agent? in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2011 May 6;30(1):50. doi: 10.1186/1756-9966-30-50.
2011
AOU San Luigi di Orbassano
Novello S; Milella M; Tiseo M; Banna G; Cortinovis D; Di Maio M; Garassino M; Maione P; Martelli O; Vavalà T; Bria E;
Pulmonary toxicity related to systemic treatment of nonsmall cell lung cancer. in Cancer / Cancer. 2011 Jul 15;117(14):3069-80. doi: 10.1002/cncr.25894. Epub 2011 Jan 31.
2011
AOU San Luigi di Orbassano
De Sanctis A; Taillade L; Vignot S; Novello S; Conforti R; Spano JP; Scagliotti GV; Khayat D;
Phase II trial of NGR-hTNF and doxorubicin in relapsed small cell lung cancer (SCLC) in Journal of Clinical Oncology
2011
AOU San Luigi di Orbassano
Vigano' MG; Cavina R; Novello S; Grossi F; Santoro A; Gregorc V; Scagliotti G; Garassino IM; Rossoni G; Levra MG; Genova C; Caligaris-Cappio F; Lambiase A; Bordignon C;
Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2010 Apr 10;28(11):1835-42. doi: 10.1200/JCO.2009.26.1321. Epub 2010 Mar 8.
2010
AOU San Luigi di Orbassano
Scagliotti G; Novello S; von Pawel J; Reck M; Pereira JR; Thomas M; Abrão Miziara JE; Balint B; De Marinis F; Keller A; Arén O; Csollak M; Albert I; Barrios CH; Grossi F; Krzakowski M; Cupit L; Cihon F; Dimatteo S; Hanna N;
The pulmonary nodule: clinical and radiological characteristics affecting a diagnosis of malignancy. in La Radiologia medica / Radiol Med. 2009 Sep;114(6):871-89. doi: 10.1007/s11547-009-0399-1. Epub 2009 May 29.
2009
AOU San Luigi di Orbassano
Cardinale L; Ardissone F; Novello S; Busso M; Solitro F; Longo M; Sardo D; Giors M; Fava C;
Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin. in Molecular cancer therapeutics / Mol Cancer Ther. 2009 Nov;8(11):3066-74. doi: 10.1158/1535-7163.MCT-09-0151. Epub 2009 Oct 27.
2009
AOU San Luigi di Orbassano
Ceppi P; Papotti M; Monica V; Lo Iacono M; Saviozzi S; Pautasso M; Novello S; Mussino S; Bracco E; Volante M; Scagliotti GV;
Nonsmall cell lung cancer in never smokers. in Current opinion in oncology / Curr Opin Oncol. 2009 Mar;21(2):99-104. doi: 10.1097/CCO.0b013e328321049e.
2009
AOU San Luigi di Orbassano
Scagliotti GV; Longo M; Novello S;
Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2009 Feb 1;15(3):1039-45. doi: 10.1158/1078-0432.CCR-08-1227.
2009
AOU San Luigi di Orbassano
Ceppi P; Novello S; Cambieri A; Longo M; Monica V; Lo Iacono M; Giaj-Levra M; Saviozzi S; Volante M; Papotti M; Scagliotti G;
Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2009 Dec 15;15(24):7547-7552. doi: 10.1158/1078-0432.CCR-09-1641.
2009
AOU San Luigi di Orbassano
Monica V; Scagliotti GV; Ceppi P; Righi L; Cambieri A; Lo Iacono M; Saviozzi S; Volante M; Novello S; Papotti M;
Lung cancer and women. in Future oncology (London, England) / Future Oncol. 2008 Oct;4(5):705-16. doi: 10.2217/14796694.4.5.705.
2008
AOU San Luigi di Orbassano
Novello S; Vavalà T;
Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2008 Jun;3(6):583-9. doi: 10.1097/JTO.0b013e3181734f24.
2008
AOU San Luigi di Orbassano
Ceppi P; Longo M; Volante M; Novello S; Cappia S; Bacillo E; Selvaggi G; Saviozzi S; Calogero R; Papotti M; Scagliotti GV;
Lung cancer stage is an independent risk factor for surgical mortality in Tumori
2008
AOU San Luigi di Orbassano
Pastorino U; Borasio P; Francese M; Miceli R; Calabrò E; Solli P; Leo F; Novello S; Scagliotti G; Mariani L;
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2007 May;18(5):903-8. doi: 10.1093/annonc/mdm061. Epub 2007 Mar 9.
2007
AOU San Luigi di Orbassano
Novello S; Bruzzi P; Barone C; Buosi R; Masotti A; Michetti G; Fioretti M; Barbera S; Spatafora M; Garetto L; Mazzanti P; Dongiovanni V; Selvaggi G; Crinò L; Scagliotti GV;
Accuracy of CT-guided transthoracic needle biopsy of lung lesions: factors affecting diagnostic yield. in La Radiologia medica / Radiol Med. 2007 Dec;112(8):1142-59. doi: 10.1007/s11547-007-0212-y. Epub 2007 Dec 13.
2007
AOU San Luigi di Orbassano
Priola AM; Priola SM; Cataldi A; Errico L; Di Franco M; Campisi P; Molinaro L; Marci V; Novello S; Fava C;
Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2006 Oct 20;24(30):4818-24. doi: 10.1200/JCO.2006.06.1952.
2006
AOU San Luigi di Orbassano
Papotti M; Kalebic T; Volante M; Chiusa L; Bacillo E; Cappia S; Lausi P; Novello S; Borasio P; Scagliotti GV;
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase. in Cancer / Cancer. 2006 Oct 1;107(7):1589-96. doi: 10.1002/cncr.22208.
2006
AOU San Luigi di Orbassano
Ceppi P; Volante M; Saviozzi S; Rapa I; Novello S; Cambieri A; Lo Iacono M; Cappia S; Papotti M; Scagliotti GV;
Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2006 May;7(6):395-400. doi: 10.3816/CLC.2006.n.023.
2006
AOU San Luigi di Orbassano
Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV;
The way forward: new drugs and new therapeutic strategies in lung cancer therapy. in Clinical lung cancer / Clin Lung Cancer. 2006 May;7 Suppl 4:S109-10. doi: 10.3816/clc.2006.s.001.
2006
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2005 Oct;16(10):1662-6. doi: 10.1093/annonc/mdi314. Epub 2005 Jul 8.
2005
AOU San Luigi di Orbassano
Novello S; Fava C; Borasio P; Dogliotti L; Cortese G; Crida B; Selvaggi G; Lausi P; Brizzi MP; Sperone P; Cardinale L; Ferraris F; Perotto F; Priola A; Scagliotti GV;
Low dose CT in early lung cancer diagnosis: Prevalence data. in La Radiologia medica / Radiol Med. 2005 Nov-Dec;110(5-6):532-43.
2005
AOU San Luigi di Orbassano
Cardinale L; Cortese G; Borasio P; Dogliotti L; Ferraris F; Novello S; Perotto F; Scagliotti G; Fava C;
Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):690-6.
2005
AOU San Luigi di Orbassano
Scagliotti GV; Kortsik C; Dark GG; Price A; Manegold C; Rosell R; O'Brien M; Peterson PM; Castellano D; Selvaggi G; Novello S; Blatter J; Kayitalire L; Crino L; Paz-Ares L;
State of the art in mesothelioma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2005;16 Suppl 2:ii240-5. doi: 10.1093/annonc/mdi703.
2005
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Pemetrexed in front-line chemotherapy for advanced non-small-cell lung cancer. in Oncology (Williston Park, N.Y.) / Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):32-7.
2004
AOU San Luigi di Orbassano
Scagliotti GV; Novello S; Crino L; Rosell R;
Current development of adjuvant treatment of non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2004 Dec;6 Suppl 2:S63-70. doi: 10.3816/clc.2004.s.016.
2004
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Pemetrexed and its emerging role in the treatment of thoracic malignancies. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2003 May;12(5):853-63. doi: 10.1517/13543784.12.5.853.
2003
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Adjuvant therapy in completely resected non-small-cell lung cancer. in Current oncology reports / Curr Oncol Rep. 2003 Jul;5(4):318-25. doi: 10.1007/s11912-003-0074-y.
2003
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Adjuvant chemotherapy after complete resection for early stage NSCLC. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2003 Dec;42 Suppl 1:S47-51. doi: 10.1016/s0169-5002(03)00304-0.
2003
AOU San Luigi di Orbassano
Scagliotti G; Novello S;
Efficacy of neoadjuvant strategies with gemcitabine and other chemotherapy in resectable non-small cell lung cancer: a combined modality approach. in Seminars in oncology / Semin Oncol. 2003 Aug;30(4 Suppl 10):13-8. doi: 10.1016/s0093-7754(03)00280-x.
2003
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Chemotherapy for non-small-cell lung cancer. Part 2: Advanced disease. in Oncology (Williston Park, N.Y.) / Oncology (Williston Park). 2003 Apr;17(4):457-64, 469-71; discussion 471, 478-80, 483-4.
2003
AOU San Luigi di Orbassano
Novello S; Le Chevalier T;
Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2002 Nov;38 Suppl 2:S13-9. doi: 10.1016/s0169-5002(02)00352-5.
2002
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival. in Cancer / Cancer. 2002 May 15;94(10):2669-74. doi: 10.1002/cncr.10531.
2002
AOU San Luigi di Orbassano
Selvaggi G; Scagliotti GV; Torri V; Novello S; Leonardo E; Cappia S; Mossetti C; Ardissone F; Lausi P; Borasio P;
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Nov;34(2):261-9. doi: 10.1016/s0169-5002(01)00238-0.
2001
AOU San Luigi di Orbassano
Novello S; Galli L; Antonuzzo A; Crinó L; Pozzi E; Selvaggi G; Ricci S; Marrocolo F; Darwish S; Sorbolini S; Tonato M; Scagliotti GV;
Role of erythropoietin in the treatment of lung cancer associated anaemia. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Dec;34 Suppl 4:S91-4. doi: 10.1016/s0169-5002(01)00398-1.
2001
AOU San Luigi di Orbassano
Scagliotti GV; Novello S;
Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 1999 Jul;25(1):39-46. doi: 10.1016/s0169-5002(99)00048-3.
1999
AOU San Luigi di Orbassano
Scagliotti GV; Crinó L; Pozzi E; Corgna E; Selvaggi G; Novello S; Salsano G; Gentile A; Palladino M; Marracolo F; Tonato M;
Multidrug resistance in non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 1999;10 Suppl 5:S83-6. doi: 10.1093/annonc/10.suppl_5.s83.
1999
AOU San Luigi di Orbassano
Scagliotti GV; Novello S; Selvaggi G;
Neo-adjuvant chemotherapy prior to surgery in stage III non-small cell lung cancer. in Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Monaldi Arch Chest Dis. 1997 Dec;52(6):531-4.
1997
AOU San Luigi di Orbassano
Scagliotti GV; Ferrari G; Novello S;